| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | actin filament binding | MYH2 MYH7 SHROOM3 MYH13 MYO6 SPTB SPTBN1 SPTBN4 SPTBN5 ABLIM1 MICALL2 MYH14 FHOD1 PLEC | 7.47e-09 | 227 | 167 | 14 | GO:0051015 |
| GeneOntologyMolecularFunction | structural constituent of cytoskeleton | 1.44e-07 | 130 | 167 | 10 | GO:0005200 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | MYH2 MAP9 DLG5 MYH7 SHROOM3 MYH13 CALD1 MYO6 SPTB SPTBN1 NUMA1 CCDC187 SPTBN4 SPTBN5 ABLIM1 MICALL2 MYH14 SUN2 FHOD1 LRRC27 MTCL1 SNAP25 KIFC3 PLEC CROCC DYNC1I1 TBCC | 4.45e-07 | 1099 | 167 | 27 | GO:0008092 |
| GeneOntologyMolecularFunction | actin binding | MYH2 MYH7 SHROOM3 MYH13 CALD1 MYO6 SPTB SPTBN1 SPTBN4 SPTBN5 ABLIM1 MICALL2 MYH14 FHOD1 LRRC27 PLEC CROCC | 5.89e-07 | 479 | 167 | 17 | GO:0003779 |
| GeneOntologyMolecularFunction | cytidine kinase activity | 2.28e-06 | 4 | 167 | 3 | GO:0043771 | |
| GeneOntologyMolecularFunction | uridine kinase activity | 2.28e-06 | 4 | 167 | 3 | GO:0004849 | |
| GeneOntologyMolecularFunction | microfilament motor activity | 1.55e-05 | 38 | 167 | 5 | GO:0000146 | |
| GeneOntologyMolecularFunction | ankyrin binding | 3.69e-05 | 23 | 167 | 4 | GO:0030506 | |
| GeneOntologyMolecularFunction | nucleoside kinase activity | 4.65e-05 | 9 | 167 | 3 | GO:0019206 | |
| GeneOntologyMolecularFunction | GTPase binding | BICDL2 DMXL2 SPTBN1 AMBRA1 PLEKHG2 ODF2 DENND1A CSE1L MICALL2 MAP3K11 AKAP13 RAB11FIP3 | 5.27e-05 | 360 | 167 | 12 | GO:0051020 |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 6.11e-05 | 118 | 167 | 7 | GO:0003774 | |
| GeneOntologyMolecularFunction | structural constituent of nuclear lamina | 6.95e-05 | 2 | 167 | 2 | GO:0160123 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | CUL4A TCF4 DLG5 TRIM15 WWC3 AMBRA1 ATG2A DDIT3 STX12 SPTBN4 PARP10 NCOR1 NCOR2 WTIP SUN2 BRD4 AKAP13 KDM2A SNAP25 RERE EPN1 SPEN RAB11FIP3 | 1.03e-04 | 1160 | 167 | 23 | GO:0030674 |
| GeneOntologyMolecularFunction | molecular adaptor activity | CUL4A TCF4 DLG5 TRIM15 WWC3 AMBRA1 ATG2A DDIT3 STX12 SPTBN4 PARP10 NCOR1 NCOR2 WTIP MYH14 SUN2 BRD4 EIF4G1 AKAP13 KDM2A SNAP25 RERE EPN1 SPEN RAB11FIP3 | 1.58e-04 | 1356 | 167 | 25 | GO:0060090 |
| GeneOntologyMolecularFunction | structural molecule activity | KRT18 PPFIA2 SPTB SPTBN1 NUMA1 TSGA10 LAMB3 LAMC1 LMNB2 MAP7 ODF2 PPL KRT73 SPTBN4 LMNA LMNB1 EIF3A PLEC CROCC | 1.73e-04 | 891 | 167 | 19 | GO:0005198 |
| GeneOntologyMolecularFunction | small GTPase binding | BICDL2 DMXL2 PLEKHG2 ODF2 DENND1A CSE1L MICALL2 MAP3K11 AKAP13 RAB11FIP3 | 3.83e-04 | 321 | 167 | 10 | GO:0031267 |
| GeneOntologyMolecularFunction | nucleobase-containing compound kinase activity | 6.36e-04 | 47 | 167 | 4 | GO:0019205 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | MYH2 MYH7 ABCF3 MYH13 MYO6 ATP13A1 DHX40 ATP10B CHD8 MYH14 KIFC3 SNRNP200 ABCG8 DYNC1I1 | 6.69e-04 | 614 | 167 | 14 | GO:0140657 |
| GeneOntologyMolecularFunction | transcription corepressor activity | 7.03e-04 | 229 | 167 | 8 | GO:0003714 | |
| GeneOntologyMolecularFunction | calmodulin binding | 7.24e-04 | 230 | 167 | 8 | GO:0005516 | |
| GeneOntologyMolecularFunction | histone H3K4me/H3K4me2/H3K4me3 demethylase activity | 1.02e-03 | 6 | 167 | 2 | GO:0034647 | |
| GeneOntologyMolecularFunction | K63-linked polyubiquitin modification-dependent protein binding | 1.30e-03 | 26 | 167 | 3 | GO:0070530 | |
| GeneOntologyMolecularFunction | histone H3 demethylase activity | 1.61e-03 | 28 | 167 | 3 | GO:0141052 | |
| GeneOntologyMolecularFunction | histone H3K4 demethylase activity | 1.88e-03 | 8 | 167 | 2 | GO:0032453 | |
| GeneOntologyMolecularFunction | histone demethylase activity | 2.17e-03 | 31 | 167 | 3 | GO:0032452 | |
| GeneOntologyMolecularFunction | basal RNA polymerase II transcription machinery binding | 2.27e-03 | 66 | 167 | 4 | GO:0001099 | |
| GeneOntologyMolecularFunction | basal transcription machinery binding | 2.27e-03 | 66 | 167 | 4 | GO:0001098 | |
| GeneOntologyMolecularFunction | protein demethylase activity | 2.38e-03 | 32 | 167 | 3 | GO:0140457 | |
| GeneOntologyMolecularFunction | phosphatase regulator activity | 2.62e-03 | 113 | 167 | 5 | GO:0019208 | |
| GeneOntologyMolecularFunction | spectrin binding | 2.84e-03 | 34 | 167 | 3 | GO:0030507 | |
| GeneOntologyMolecularFunction | manganese ion transmembrane transporter activity | 2.99e-03 | 10 | 167 | 2 | GO:0005384 | |
| GeneOntologyMolecularFunction | guanyl-nucleotide exchange factor activity | 3.36e-03 | 231 | 167 | 7 | GO:0005085 | |
| GeneOntologyMolecularFunction | RNA polymerase II C-terminal domain binding | 3.64e-03 | 11 | 167 | 2 | GO:0099122 | |
| GeneOntologyBiologicalProcess | CTP salvage | 5.31e-07 | 3 | 168 | 3 | GO:0044211 | |
| GeneOntologyBiologicalProcess | CMP biosynthetic process | 2.11e-06 | 4 | 168 | 3 | GO:0009224 | |
| GeneOntologyBiologicalProcess | nuclear pore localization | 5.24e-06 | 5 | 168 | 3 | GO:0051664 | |
| GeneOntologyBiologicalProcess | CTP biosynthetic process | 5.40e-06 | 15 | 168 | 4 | GO:0006241 | |
| GeneOntologyBiologicalProcess | pyrimidine ribonucleoside triphosphate biosynthetic process | 7.16e-06 | 16 | 168 | 4 | GO:0009209 | |
| GeneOntologyBiologicalProcess | nuclear migration | 7.76e-06 | 34 | 168 | 5 | GO:0007097 | |
| GeneOntologyBiologicalProcess | CTP metabolic process | 9.30e-06 | 17 | 168 | 4 | GO:0046036 | |
| GeneOntologyBiologicalProcess | UMP salvage | 1.04e-05 | 6 | 168 | 3 | GO:0044206 | |
| GeneOntologyBiologicalProcess | pyrimidine nucleotide salvage | 1.04e-05 | 6 | 168 | 3 | GO:0032262 | |
| GeneOntologyBiologicalProcess | pyrimidine ribonucleotide salvage | 1.04e-05 | 6 | 168 | 3 | GO:0010138 | |
| GeneOntologyBiologicalProcess | pyrimidine ribonucleoside triphosphate metabolic process | 1.50e-05 | 19 | 168 | 4 | GO:0009208 | |
| GeneOntologyBiologicalProcess | actin filament-based process | MYH2 MYH7 SHROOM3 CALD1 MYO6 PPFIA1 SPTB SPTBN1 ADGRB1 ARHGEF18 PLEKHG2 KANK2 SPTBN4 SPTBN5 MICALL2 MYH14 SUN2 FHOD1 AKAP13 PLEC FCHSD1 | 1.73e-05 | 912 | 168 | 21 | GO:0030029 |
| GeneOntologyBiologicalProcess | pyrimidine-containing compound salvage | 1.81e-05 | 7 | 168 | 3 | GO:0008655 | |
| GeneOntologyBiologicalProcess | pyrimidine nucleoside triphosphate biosynthetic process | 1.86e-05 | 20 | 168 | 4 | GO:0009148 | |
| GeneOntologyBiologicalProcess | actin filament organization | SHROOM3 CALD1 MYO6 PPFIA1 SPTB SPTBN1 ARHGEF18 PLEKHG2 KANK2 SPTBN4 SPTBN5 MICALL2 FHOD1 PLEC FCHSD1 | 1.89e-05 | 509 | 168 | 15 | GO:0007015 |
| GeneOntologyBiologicalProcess | nucleus localization | 2.84e-05 | 44 | 168 | 5 | GO:0051647 | |
| GeneOntologyBiologicalProcess | actin cytoskeleton organization | MYH7 SHROOM3 CALD1 MYO6 PPFIA1 SPTB SPTBN1 ADGRB1 ARHGEF18 PLEKHG2 KANK2 SPTBN4 SPTBN5 MICALL2 MYH14 FHOD1 AKAP13 PLEC FCHSD1 | 3.11e-05 | 803 | 168 | 19 | GO:0030036 |
| GeneOntologyBiologicalProcess | pyrimidine ribonucleotide biosynthetic process | 4.70e-05 | 25 | 168 | 4 | GO:0009220 | |
| GeneOntologyBiologicalProcess | pyrimidine nucleoside triphosphate metabolic process | 4.70e-05 | 25 | 168 | 4 | GO:0009147 | |
| GeneOntologyBiologicalProcess | UMP biosynthetic process | 8.35e-05 | 11 | 168 | 3 | GO:0006222 | |
| GeneOntologyBiologicalProcess | CMP metabolic process | 8.35e-05 | 11 | 168 | 3 | GO:0046035 | |
| GeneOntologyBiologicalProcess | regulation of cellular component biogenesis | DLG5 PPFIA1 SPTB SPTBN1 NUMA1 ADGRB1 AMBRA1 ARHGEF18 MARCHF7 PLEKHG2 ATG2A ODF2 KANK2 CNTROB SPTBN4 SPTBN5 FHOD1 EIF4G1 SNAP25 CROCC EPN1 FCHSD1 RAB11FIP3 | 1.01e-04 | 1189 | 168 | 23 | GO:0044087 |
| GeneOntologyBiologicalProcess | pyrimidine ribonucleoside monophosphate biosynthetic process | 1.11e-04 | 12 | 168 | 3 | GO:0009174 | |
| GeneOntologyBiologicalProcess | regulation of protein polymerization | 1.20e-04 | 231 | 168 | 9 | GO:0032271 | |
| GeneOntologyBiologicalProcess | pyrimidine nucleotide biosynthetic process | 1.45e-04 | 33 | 168 | 4 | GO:0006221 | |
| GeneOntologyBiologicalProcess | pyrimidine ribonucleotide metabolic process | 1.63e-04 | 34 | 168 | 4 | GO:0009218 | |
| GeneOntologyBiologicalProcess | actin filament polymerization | 1.70e-04 | 190 | 168 | 8 | GO:0030041 | |
| GeneOntologyBiologicalProcess | protein localization to nuclear envelope | 1.81e-04 | 14 | 168 | 3 | GO:0090435 | |
| GeneOntologyBiologicalProcess | regulation of actin filament organization | PPFIA1 SPTB SPTBN1 ARHGEF18 PLEKHG2 KANK2 SPTBN4 SPTBN5 FHOD1 FCHSD1 | 1.82e-04 | 300 | 168 | 10 | GO:0110053 |
| GeneOntologyBiologicalProcess | regulation of supramolecular fiber organization | PPFIA1 SPTB SPTBN1 NUMA1 ARHGEF18 PLEKHG2 KANK2 SPTBN4 SPTBN5 FHOD1 AKAP13 FCHSD1 | 2.59e-04 | 438 | 168 | 12 | GO:1902903 |
| GeneOntologyBiologicalProcess | centrosome separation | 2.75e-04 | 16 | 168 | 3 | GO:0051299 | |
| GeneOntologyBiologicalProcess | UMP metabolic process | 2.75e-04 | 16 | 168 | 3 | GO:0046049 | |
| GeneOntologyBiologicalProcess | regulation of actin filament polymerization | 2.96e-04 | 156 | 168 | 7 | GO:0030833 | |
| GeneOntologyBiologicalProcess | supramolecular fiber organization | MYH7 SHROOM3 CALD1 MYO6 PPFIA1 SPTB SPTBN1 NUMA1 ARHGEF18 PLEKHG2 KANK2 KRT73 SPTBN4 SPTBN5 MICALL2 FHOD1 AKAP13 PLEC FCHSD1 | 3.06e-04 | 957 | 168 | 19 | GO:0097435 |
| GeneOntologyBiologicalProcess | regulation of actin cytoskeleton organization | PPFIA1 SPTB SPTBN1 ARHGEF18 PLEKHG2 KANK2 SPTBN4 SPTBN5 FHOD1 AKAP13 FCHSD1 | 3.21e-04 | 384 | 168 | 11 | GO:0032956 |
| GeneOntologyBiologicalProcess | pyrimidine ribonucleoside monophosphate metabolic process | 3.32e-04 | 17 | 168 | 3 | GO:0009173 | |
| GeneOntologyBiologicalProcess | negative regulation of actin filament polymerization | 3.68e-04 | 75 | 168 | 5 | GO:0030837 | |
| GeneOntologyBiologicalProcess | organelle assembly | MAP9 MYH7 CEP85 RRP7BP DZIP1L CNTRL NUMA1 AMBRA1 MARCHF7 ATG2A ODF2 CNTROB STX12 NCOR1 ABLIM1 PRRC2C TEKT1 AKAP13 PLEC CROCC RAB11FIP3 | 3.89e-04 | 1138 | 168 | 21 | GO:0070925 |
| GeneOntologyBiologicalProcess | microtubule-based process | BICDL2 MAP9 CEP85 CNTRL ASH1L NUMA1 CCDC187 MAP7 ODF2 CNTROB NCOR1 LMNA SUN2 MAP3K11 TEKT1 KATNIP MTCL1 KIFC3 CROCC DYNC1I1 | 3.97e-04 | 1058 | 168 | 20 | GO:0007017 |
| GeneOntologyBiologicalProcess | endomembrane system organization | MYH2 SPTB SPTBN1 LMNB2 LYSMD3 STX12 SPTBN5 LMNA LMNB1 SYNJ1 SUN2 TJAP1 SNAP25 KIFC3 PLEC | 4.09e-04 | 672 | 168 | 15 | GO:0010256 |
| GeneOntologyBiologicalProcess | pyrimidine-containing compound biosynthetic process | 4.09e-04 | 43 | 168 | 4 | GO:0072528 | |
| GeneOntologyBiologicalProcess | protein polymerization | SPTB SPTBN1 NUMA1 AMBRA1 PLEKHG2 KANK2 SPTBN4 SPTBN5 MICALL2 FCHSD1 | 4.26e-04 | 334 | 168 | 10 | GO:0051258 |
| GeneOntologyBiologicalProcess | pyrimidine nucleoside monophosphate biosynthetic process | 4.67e-04 | 19 | 168 | 3 | GO:0009130 | |
| GeneOntologyBiologicalProcess | intracellular transport | BICDL2 CCHCR1 SMG1 MYO6 PPFIA2 NOL6 NUMA1 LMNB2 SNUPN DENND1A STX12 SPTBN5 CSE1L LMNA LMNB1 MICALL2 UBR5 SUN2 FHOD1 SNX8 AKAP13 SNAP25 NAGPA DYNC1I1 RAB11FIP3 | 4.70e-04 | 1496 | 168 | 25 | GO:0046907 |
| GeneOntologyBiologicalProcess | actin polymerization or depolymerization | 4.84e-04 | 222 | 168 | 8 | GO:0008154 | |
| GeneOntologyBiologicalProcess | membrane organization | MYH2 SPTB SPTBN1 ADGRB1 CHCHD6 ATP10B LMNB2 ATG2A STX12 SPTBN4 LMNA LMNB1 SYNJ1 SUN2 SNAP25 PLEC EPN1 FCHSD1 | 4.88e-04 | 914 | 168 | 18 | GO:0061024 |
| GeneOntologyBiologicalProcess | nucleus organization | 4.96e-04 | 170 | 168 | 7 | GO:0006997 | |
| GeneOntologyBiologicalProcess | actin filament capping | 5.31e-04 | 46 | 168 | 4 | GO:0051693 | |
| GeneOntologyBiologicalProcess | vesicle-mediated transport to the plasma membrane | 5.32e-04 | 172 | 168 | 7 | GO:0098876 | |
| GeneOntologyBiologicalProcess | regulation of organelle organization | SMG1 MAP9 PPFIA1 SPTB SPTBN1 NUMA1 AMBRA1 ARHGEF18 MARCHF7 PLEKHG2 ATG2A ODF2 KANK2 CNTROB SPTBN4 SPTBN5 LMNA SYNJ1 FHOD1 AKAP13 CROCC FCHSD1 RAB11FIP3 | 5.72e-04 | 1342 | 168 | 23 | GO:0033043 |
| GeneOntologyBiologicalProcess | regulation of actin polymerization or depolymerization | 6.31e-04 | 177 | 168 | 7 | GO:0008064 | |
| GeneOntologyBiologicalProcess | regulation of actin filament length | 6.97e-04 | 180 | 168 | 7 | GO:0030832 | |
| GeneOntologyBiologicalProcess | negative regulation of hippo signaling | 7.29e-04 | 22 | 168 | 3 | GO:0035331 | |
| GeneOntologyBiologicalProcess | actomyosin structure organization | 7.84e-04 | 239 | 168 | 8 | GO:0031032 | |
| GeneOntologyBiologicalProcess | negative regulation of intracellular signal transduction | DLG5 TRIM15 WWC3 TNIP2 ASH1L MARCHF7 KANK2 DDIT3 NCOR1 NCOR2 YJU2 WTIP BRD4 CCAR2 EIF3A PPM1N | 8.04e-04 | 795 | 168 | 16 | GO:1902532 |
| GeneOntologyBiologicalProcess | negative regulation of actin filament depolymerization | 8.48e-04 | 52 | 168 | 4 | GO:0030835 | |
| GeneOntologyBiologicalProcess | negative regulation of protein polymerization | 8.93e-04 | 91 | 168 | 5 | GO:0032272 | |
| GeneOntologyBiologicalProcess | regulation of cytoskeleton organization | MAP9 PPFIA1 SPTB SPTBN1 NUMA1 ARHGEF18 PLEKHG2 KANK2 SPTBN4 SPTBN5 FHOD1 AKAP13 FCHSD1 | 9.44e-04 | 579 | 168 | 13 | GO:0051493 |
| GeneOntologyBiologicalProcess | regulation of DNA damage checkpoint | 9.47e-04 | 24 | 168 | 3 | GO:2000001 | |
| GeneOntologyBiologicalProcess | regulation of actin filament-based process | PPFIA1 SPTB SPTBN1 ARHGEF18 PLEKHG2 KANK2 SPTBN4 SPTBN5 FHOD1 AKAP13 FCHSD1 | 9.56e-04 | 438 | 168 | 11 | GO:0032970 |
| GeneOntologyBiologicalProcess | hemidesmosome assembly | 9.68e-04 | 6 | 168 | 2 | GO:0031581 | |
| GeneOntologyBiologicalProcess | spliceosomal conformational changes to generate catalytic conformation | 9.68e-04 | 6 | 168 | 2 | GO:0000393 | |
| GeneOntologyBiologicalProcess | pyrimidine nucleotide metabolic process | 1.05e-03 | 55 | 168 | 4 | GO:0006220 | |
| GeneOntologyBiologicalProcess | negative regulation of cytoskeleton organization | 1.08e-03 | 194 | 168 | 7 | GO:0051494 | |
| GeneOntologyBiologicalProcess | negative regulation of supramolecular fiber organization | 1.18e-03 | 197 | 168 | 7 | GO:1902904 | |
| GeneOntologyBiologicalProcess | nucleotide salvage | 1.20e-03 | 26 | 168 | 3 | GO:0043173 | |
| GeneOntologyBiologicalProcess | pyrimidine nucleoside monophosphate metabolic process | 1.20e-03 | 26 | 168 | 3 | GO:0009129 | |
| GeneOntologyCellularComponent | supramolecular fiber | MYH2 MAP9 MYH7 SHROOM3 MYH13 CALD1 KRT18 MYO6 VMAC PPP1R12B SPTBN1 NUMA1 LMNB2 MAP7 ODF2 PPL KRT73 SPTBN4 LMNA LMNB1 SYNJ1 MYH14 LRRC27 MAP3K11 TEKT1 AKAP13 EIF3A MTCL1 KIFC3 PLEC DYNC1I1 TBCC AHNAK2 | 1.95e-10 | 1179 | 166 | 33 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | MYH2 MAP9 MYH7 SHROOM3 MYH13 CALD1 KRT18 MYO6 VMAC PPP1R12B SPTBN1 NUMA1 LMNB2 MAP7 ODF2 PPL KRT73 SPTBN4 LMNA LMNB1 SYNJ1 MYH14 LRRC27 MAP3K11 TEKT1 AKAP13 EIF3A MTCL1 KIFC3 PLEC DYNC1I1 TBCC AHNAK2 | 2.32e-10 | 1187 | 166 | 33 | GO:0099081 |
| GeneOntologyCellularComponent | actin cytoskeleton | MYH2 MYH7 SHROOM3 MYH13 CALD1 MYO6 PPP1R12B SPTB SPTBN1 DAPK1 SPTBN4 SPTBN5 ABLIM1 MICALL2 MYH14 FHOD1 AKAP13 SNAP25 CROCC PPP1R12C FCHSD1 CCDC102A | 1.16e-09 | 576 | 166 | 22 | GO:0015629 |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | MAP9 SHROOM3 CALD1 KRT18 MYO6 VMAC NUMA1 LMNB2 MAP7 ODF2 PPL KRT73 SPTBN4 LMNA LMNB1 SYNJ1 MAP3K11 TEKT1 AKAP13 EIF3A MTCL1 KIFC3 PLEC DYNC1I1 TBCC | 4.71e-08 | 899 | 166 | 25 | GO:0099513 |
| GeneOntologyCellularComponent | cortical actin cytoskeleton | 5.49e-08 | 93 | 166 | 9 | GO:0030864 | |
| GeneOntologyCellularComponent | cortical cytoskeleton | MYH2 SHROOM3 CALD1 SPTB SPTBN1 NUMA1 SPTBN4 SPTBN5 AKAP13 FCHSD1 | 8.29e-08 | 129 | 166 | 10 | GO:0030863 |
| GeneOntologyCellularComponent | spectrin | 4.68e-07 | 9 | 166 | 4 | GO:0008091 | |
| GeneOntologyCellularComponent | contractile actin filament bundle | 2.23e-06 | 107 | 166 | 8 | GO:0097517 | |
| GeneOntologyCellularComponent | stress fiber | 2.23e-06 | 107 | 166 | 8 | GO:0001725 | |
| GeneOntologyCellularComponent | actomyosin | 4.37e-06 | 117 | 166 | 8 | GO:0042641 | |
| GeneOntologyCellularComponent | actin filament bundle | 4.66e-06 | 118 | 166 | 8 | GO:0032432 | |
| GeneOntologyCellularComponent | myosin complex | 7.29e-06 | 59 | 166 | 6 | GO:0016459 | |
| GeneOntologyCellularComponent | cell cortex | MYH2 SHROOM3 CEP85 CALD1 MYO6 SPTB SPTBN1 NUMA1 SPTBN4 SPTBN5 AKAP13 SNAP25 FCHSD1 | 8.79e-06 | 371 | 166 | 13 | GO:0005938 |
| GeneOntologyCellularComponent | lamin filament | 9.66e-06 | 6 | 166 | 3 | GO:0005638 | |
| GeneOntologyCellularComponent | anchoring junction | MYH2 DCHS2 DLG5 TRIM15 SHROOM3 KRT18 PPFIA1 ASH1L ADGRB1 AMBRA1 ITGA7 PPL SPTBN4 PLEKHG4B MICALL2 WTIP FHOD1 TJAP1 GNA12 KIFC3 PLEC | 3.22e-05 | 976 | 166 | 21 | GO:0070161 |
| GeneOntologyCellularComponent | myosin filament | 4.26e-05 | 25 | 166 | 4 | GO:0032982 | |
| GeneOntologyCellularComponent | myosin II complex | 6.77e-05 | 28 | 166 | 4 | GO:0016460 | |
| GeneOntologyCellularComponent | centriole | 7.14e-05 | 172 | 166 | 8 | GO:0005814 | |
| GeneOntologyCellularComponent | cell-cell junction | MYH2 DCHS2 DLG5 SHROOM3 KRT18 ASH1L ADGRB1 PPL SPTBN4 PLEKHG4B MICALL2 WTIP FHOD1 TJAP1 KIFC3 | 7.75e-05 | 591 | 166 | 15 | GO:0005911 |
| GeneOntologyCellularComponent | CURI complex | 1.87e-04 | 3 | 166 | 2 | GO:0032545 | |
| GeneOntologyCellularComponent | UTP-C complex | 1.87e-04 | 3 | 166 | 2 | GO:0034456 | |
| GeneOntologyCellularComponent | muscle myosin complex | 2.55e-04 | 16 | 166 | 3 | GO:0005859 | |
| GeneOntologyCellularComponent | nuclear lamina | 3.08e-04 | 17 | 166 | 3 | GO:0005652 | |
| GeneOntologyCellularComponent | myofibril | 3.44e-04 | 273 | 166 | 9 | GO:0030016 | |
| GeneOntologyCellularComponent | microtubule | MAP9 SHROOM3 NUMA1 MAP7 ODF2 SYNJ1 MAP3K11 TEKT1 EIF3A MTCL1 KIFC3 DYNC1I1 TBCC | 3.45e-04 | 533 | 166 | 13 | GO:0005874 |
| GeneOntologyCellularComponent | microtubule organizing center | CCHCR1 DLG5 CEP85 KRT18 DZIP1L CNTRL CCNP NUMA1 TSGA10 CCDC187 MARCHF7 ODF2 CNTROB CROCC2 MAP3K11 KIFC3 CROCC RAB11FIP3 | 3.84e-04 | 919 | 166 | 18 | GO:0005815 |
| GeneOntologyCellularComponent | nuclear periphery | 4.42e-04 | 171 | 166 | 7 | GO:0034399 | |
| GeneOntologyCellularComponent | intermediate filament | 4.74e-04 | 227 | 166 | 8 | GO:0005882 | |
| GeneOntologyCellularComponent | contractile muscle fiber | 5.33e-04 | 290 | 166 | 9 | GO:0043292 | |
| GeneOntologyCellularComponent | nuclear matrix | 8.95e-04 | 140 | 166 | 6 | GO:0016363 | |
| GeneOntologyCellularComponent | microtubule bundle | 9.21e-04 | 6 | 166 | 2 | GO:0097427 | |
| GeneOntologyCellularComponent | intermediate filament cytoskeleton | 1.23e-03 | 263 | 166 | 8 | GO:0045111 | |
| GeneOntologyCellularComponent | spectrin-associated cytoskeleton | 2.18e-03 | 9 | 166 | 2 | GO:0014731 | |
| GeneOntologyCellularComponent | centriolar subdistal appendage | 2.71e-03 | 10 | 166 | 2 | GO:0120103 | |
| GeneOntologyCellularComponent | laminin complex | 2.71e-03 | 10 | 166 | 2 | GO:0043256 | |
| GeneOntologyCellularComponent | postsynapse | DLG5 CALD1 MYO6 PPFIA2 PPFIA1 SPTB SPTBN1 ADGRB1 DAPK1 STX12 ABLIM1 EIF4G1 PLEKHA5 EIF3A SNAP25 EPN1 RAB11FIP3 | 3.09e-03 | 1018 | 166 | 17 | GO:0098794 |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | PLVAP KRT18 MYO6 CNTRL ADGRB1 AMBRA1 MAP7 NCOR1 LMNA SYNJ1 UBR5 AKAP13 SNAP25 PLEC GOLGA1 DYNC1I1 | 3.19e-03 | 934 | 166 | 16 | GO:0048471 |
| GeneOntologyCellularComponent | postsynaptic endosome membrane | 3.29e-03 | 11 | 166 | 2 | GO:0098895 | |
| GeneOntologyCellularComponent | astral microtubule | 3.29e-03 | 11 | 166 | 2 | GO:0000235 | |
| GeneOntologyCellularComponent | centrosome | CEP85 KRT18 CNTRL CCNP NUMA1 CCDC187 MARCHF7 ODF2 CNTROB CROCC2 MAP3K11 KIFC3 CROCC RAB11FIP3 | 3.40e-03 | 770 | 166 | 14 | GO:0005813 |
| GeneOntologyCellularComponent | sarcomere | 3.82e-03 | 249 | 166 | 7 | GO:0030017 | |
| GeneOntologyCellularComponent | aster | 3.93e-03 | 12 | 166 | 2 | GO:0005818 | |
| GeneOntologyCellularComponent | postsynaptic recycling endosome | 4.62e-03 | 13 | 166 | 2 | GO:0098837 | |
| GeneOntologyCellularComponent | cuticular plate | 4.62e-03 | 13 | 166 | 2 | GO:0032437 | |
| HumanPheno | Echolalia | 6.16e-05 | 46 | 48 | 5 | HP:0010529 | |
| HumanPheno | Decreased facial expression | 6.83e-05 | 151 | 48 | 8 | HP:0004673 | |
| HumanPheno | Abnormality of facial soft tissue | MYH2 DMXL2 MYH7 KDM5C SPTBN1 LMNB2 ITGA7 ADCY5 SPTBN4 LMNA SYNJ1 EIF4G1 SNAP25 PLEC SLC30A10 | 7.42e-05 | 538 | 48 | 15 | HP:0011799 |
| HumanPheno | Involuntary vocalization | 8.39e-05 | 49 | 48 | 5 | HP:4000074 | |
| HumanPheno | Proximal upper limb muscle hypertrophy | 8.70e-05 | 2 | 48 | 2 | HP:0040266 | |
| HumanPheno | Upper limb muscle hypertrophy | 8.70e-05 | 2 | 48 | 2 | HP:0040265 | |
| HumanPheno | Toe extensor amyotrophy | 8.70e-05 | 2 | 48 | 2 | HP:0011916 | |
| HumanPheno | Abnormality of facial musculature | MYH2 DMXL2 MYH7 KDM5C ITGA7 ADCY5 SPTBN4 SYNJ1 EIF4G1 SNAP25 PLEC SLC30A10 | 9.01e-05 | 361 | 48 | 12 | HP:0000301 |
| Domain | Spectrin_repeat | 1.40e-07 | 29 | 159 | 6 | IPR002017 | |
| Domain | SPEC | 2.61e-07 | 32 | 159 | 6 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 2.61e-07 | 32 | 159 | 6 | IPR018159 | |
| Domain | Myosin_tail_1 | 3.29e-07 | 18 | 159 | 5 | PF01576 | |
| Domain | Myosin_tail | 3.29e-07 | 18 | 159 | 5 | IPR002928 | |
| Domain | PRK/URK | 6.05e-07 | 3 | 159 | 3 | IPR006083 | |
| Domain | PRK | 6.05e-07 | 3 | 159 | 3 | PF00485 | |
| Domain | ACTININ_2 | 1.25e-06 | 23 | 159 | 5 | PS00020 | |
| Domain | ACTININ_1 | 1.25e-06 | 23 | 159 | 5 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 1.25e-06 | 23 | 159 | 5 | IPR001589 | |
| Domain | Uridine_kinase-like | 2.41e-06 | 4 | 159 | 3 | IPR000764 | |
| Domain | Spectrin_bsu | 2.41e-06 | 4 | 159 | 3 | IPR016343 | |
| Domain | - | 5.98e-06 | 5 | 159 | 3 | 2.60.40.1260 | |
| Domain | Lamin_tail_dom | 5.98e-06 | 5 | 159 | 3 | IPR001322 | |
| Domain | LTD | 5.98e-06 | 5 | 159 | 3 | PF00932 | |
| Domain | Myosin_N | 6.42e-06 | 15 | 159 | 4 | PF02736 | |
| Domain | Myosin_N | 6.42e-06 | 15 | 159 | 4 | IPR004009 | |
| Domain | Myosin_head_motor_dom | 1.68e-05 | 38 | 159 | 5 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 1.68e-05 | 38 | 159 | 5 | PS51456 | |
| Domain | Myosin_head | 1.68e-05 | 38 | 159 | 5 | PF00063 | |
| Domain | MYSc | 1.68e-05 | 38 | 159 | 5 | SM00242 | |
| Domain | Myosin-like_IQ_dom | 1.77e-05 | 19 | 159 | 4 | IPR027401 | |
| Domain | - | 1.77e-05 | 19 | 159 | 4 | 4.10.270.10 | |
| Domain | CH | 1.89e-05 | 65 | 159 | 6 | SM00033 | |
| Domain | CH | 2.90e-05 | 70 | 159 | 6 | PF00307 | |
| Domain | - | 3.14e-05 | 71 | 159 | 6 | 1.10.418.10 | |
| Domain | CH | 3.68e-05 | 73 | 159 | 6 | PS50021 | |
| Domain | Spectrin | 3.95e-05 | 23 | 159 | 4 | PF00435 | |
| Domain | CH-domain | 4.29e-05 | 75 | 159 | 6 | IPR001715 | |
| Domain | PH_dom-spectrin-type | 4.90e-05 | 9 | 159 | 3 | IPR001605 | |
| Domain | - | ANKRD35 PPP1R12B DAPK1 ANKZF1 KANK2 ANKRD11 AKAP13 ANKRD18A ANKRD24 PPP1R12C | 5.37e-05 | 248 | 159 | 10 | 1.25.40.20 |
| Domain | Ankyrin_rpt-contain_dom | ANKRD35 PPP1R12B DAPK1 ANKZF1 KANK2 ANKRD11 AKAP13 ANKRD18A ANKRD24 PPP1R12C | 6.56e-05 | 254 | 159 | 10 | IPR020683 |
| Domain | Lamin_B | 7.20e-05 | 2 | 159 | 2 | IPR027696 | |
| Domain | N-CoR_GPS2_interact | 7.20e-05 | 2 | 159 | 2 | IPR031557 | |
| Domain | GPS2_interact | 7.20e-05 | 2 | 159 | 2 | PF15784 | |
| Domain | Ank | ANKRD35 PPP1R12B DAPK1 ANKZF1 KANK2 ANKRD11 ANKRD18A ANKRD24 PPP1R12C | 1.50e-04 | 228 | 159 | 9 | PF00023 |
| Domain | Intermediate_filament_CS | 1.98e-04 | 63 | 159 | 5 | IPR018039 | |
| Domain | PRKG1_interact | 2.15e-04 | 3 | 159 | 2 | IPR031775 | |
| Domain | PRKG1_interact | 2.15e-04 | 3 | 159 | 2 | PF15898 | |
| Domain | MYPT1/MYPT2_chordates | 2.15e-04 | 3 | 159 | 2 | IPR017401 | |
| Domain | MYB_LIKE | 2.98e-04 | 38 | 159 | 4 | PS50090 | |
| Domain | ANK | ANKRD35 PPP1R12B DAPK1 ANKZF1 KANK2 ANKRD11 ANKRD18A ANKRD24 PPP1R12C | 3.06e-04 | 251 | 159 | 9 | SM00248 |
| Domain | ANK_REPEAT | ANKRD35 PPP1R12B DAPK1 ANKZF1 KANK2 ANKRD11 ANKRD18A ANKRD24 PPP1R12C | 3.25e-04 | 253 | 159 | 9 | PS50088 |
| Domain | P-loop_NTPase | MYH2 DLG5 MYH7 ABCF3 MYH13 MYO6 DHX40 DAPK1 CHD8 UCK1 MYH14 UCKL1 UCK2 GNA12 KIFC3 GNAZ SNRNP200 ABCG8 | 3.31e-04 | 848 | 159 | 18 | IPR027417 |
| Domain | ANK_REP_REGION | ANKRD35 PPP1R12B DAPK1 ANKZF1 KANK2 ANKRD11 ANKRD18A ANKRD24 PPP1R12C | 3.34e-04 | 254 | 159 | 9 | PS50297 |
| Domain | Filament | 3.48e-04 | 71 | 159 | 5 | SM01391 | |
| Domain | IF | 3.71e-04 | 72 | 159 | 5 | PS00226 | |
| Domain | Filament | 3.96e-04 | 73 | 159 | 5 | PF00038 | |
| Domain | Ankyrin_rpt | ANKRD35 PPP1R12B DAPK1 ANKZF1 KANK2 ANKRD11 ANKRD18A ANKRD24 PPP1R12C | 4.19e-04 | 262 | 159 | 9 | IPR002110 |
| Domain | Lys_sp_deMease-like_dom | 4.27e-04 | 4 | 159 | 2 | IPR013637 | |
| Domain | PLU-1 | 4.27e-04 | 4 | 159 | 2 | PF08429 | |
| Domain | IF | 4.77e-04 | 76 | 159 | 5 | IPR001664 | |
| Domain | Ank_2 | ANKRD35 PPP1R12B DAPK1 KANK2 ANKRD11 ANKRD18A ANKRD24 PPP1R12C | 5.19e-04 | 215 | 159 | 8 | PF12796 |
| Domain | IQ | 6.39e-04 | 81 | 159 | 5 | SM00015 | |
| Domain | zf-C5HC2 | 7.08e-04 | 5 | 159 | 2 | PF02928 | |
| Domain | Znf_C5HC2 | 7.08e-04 | 5 | 159 | 2 | IPR004198 | |
| Domain | SANT | 8.59e-04 | 50 | 159 | 4 | SM00717 | |
| Domain | SANT/Myb | 9.96e-04 | 52 | 159 | 4 | IPR001005 | |
| Domain | IQ_motif_EF-hand-BS | 1.03e-03 | 90 | 159 | 5 | IPR000048 | |
| Domain | Liprin | 1.06e-03 | 6 | 159 | 2 | IPR029515 | |
| Domain | JmjC | 1.07e-03 | 24 | 159 | 3 | PF02373 | |
| Domain | IQ | 1.19e-03 | 93 | 159 | 5 | PS50096 | |
| Domain | SANT_dom | 1.36e-03 | 26 | 159 | 3 | IPR017884 | |
| Domain | Plectin | 1.47e-03 | 7 | 159 | 2 | PF00681 | |
| Domain | Plectin_repeat | 1.47e-03 | 7 | 159 | 2 | IPR001101 | |
| Domain | PLEC | 1.47e-03 | 7 | 159 | 2 | SM00250 | |
| Domain | SANT | 1.70e-03 | 28 | 159 | 3 | PS51293 | |
| Domain | DH_1 | 2.04e-03 | 63 | 159 | 4 | PS00741 | |
| Domain | Zinc_finger_PHD-type_CS | 2.29e-03 | 65 | 159 | 4 | IPR019786 | |
| Domain | JMJC | 2.51e-03 | 32 | 159 | 3 | PS51184 | |
| Domain | JmjC_dom | 2.51e-03 | 32 | 159 | 3 | IPR003347 | |
| Domain | PH | SPTBN1 ARHGEF18 PLEKHG2 SPTBN4 PLEKHG4B SPTBN5 PLEKHA5 AKAP13 | 2.67e-03 | 278 | 159 | 8 | SM00233 |
| Domain | RhoGEF | 2.70e-03 | 68 | 159 | 4 | SM00325 | |
| Domain | PH_DOMAIN | SPTBN1 ARHGEF18 PLEKHG2 SPTBN4 PLEKHG4B SPTBN5 PLEKHA5 AKAP13 | 2.73e-03 | 279 | 159 | 8 | PS50003 |
| Domain | JmjC | 2.74e-03 | 33 | 159 | 3 | SM00558 | |
| Domain | PH_domain | SPTBN1 ARHGEF18 PLEKHG2 SPTBN4 PLEKHG4B SPTBN5 PLEKHA5 AKAP13 | 2.79e-03 | 280 | 159 | 8 | IPR001849 |
| Domain | RhoGEF | 3.00e-03 | 70 | 159 | 4 | PF00621 | |
| Domain | DH_2 | 3.00e-03 | 70 | 159 | 4 | PS50010 | |
| Domain | JmjN | 3.10e-03 | 10 | 159 | 2 | SM00545 | |
| Domain | JmjN | 3.10e-03 | 10 | 159 | 2 | PF02375 | |
| Domain | JMJN | 3.10e-03 | 10 | 159 | 2 | PS51183 | |
| Domain | JmjN | 3.10e-03 | 10 | 159 | 2 | IPR003349 | |
| Domain | IQ | 3.16e-03 | 71 | 159 | 4 | PF00612 | |
| Domain | - | 3.16e-03 | 71 | 159 | 4 | 1.20.900.10 | |
| Domain | DH-domain | 3.16e-03 | 71 | 159 | 4 | IPR000219 | |
| Domain | Myb_DNA-binding | 3.24e-03 | 35 | 159 | 3 | PF00249 | |
| Domain | PH | 3.52e-03 | 229 | 159 | 7 | PF00169 | |
| Domain | BAH | 3.77e-03 | 11 | 159 | 2 | PS51038 | |
| Domain | BAH_dom | 3.77e-03 | 11 | 159 | 2 | IPR001025 | |
| Domain | BAH | 3.77e-03 | 11 | 159 | 2 | SM00439 | |
| Domain | BAH | 3.77e-03 | 11 | 159 | 2 | PF01426 | |
| Domain | Znf_PHD-finger | 4.63e-03 | 79 | 159 | 4 | IPR019787 | |
| Domain | - | 7.03e-03 | 15 | 159 | 2 | 1.10.150.60 | |
| Domain | BRIGHT | 7.03e-03 | 15 | 159 | 2 | SM00501 | |
| Domain | ARID_dom | 7.03e-03 | 15 | 159 | 2 | IPR001606 | |
| Domain | ARID | 7.03e-03 | 15 | 159 | 2 | PS51011 | |
| Domain | ARID | 7.03e-03 | 15 | 159 | 2 | PF01388 | |
| Domain | PHD | 7.05e-03 | 89 | 159 | 4 | SM00249 | |
| Domain | Znf_PHD | 7.62e-03 | 91 | 159 | 4 | IPR001965 | |
| Domain | GproteinA_insert | 7.99e-03 | 16 | 159 | 2 | IPR011025 | |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 8.21e-07 | 10 | 114 | 4 | MM15112 | |
| Pathway | PID_CASPASE_PATHWAY | 5.53e-05 | 51 | 114 | 5 | M220 | |
| Pathway | WP_ACQUIRED_PARTIAL_LIPODYSTROPHY_BARRAQUERSIMONS_SYNDROME | 5.93e-05 | 10 | 114 | 3 | M42576 | |
| Pathway | REACTOME_PYRIMIDINE_SALVAGE | 8.11e-05 | 11 | 114 | 3 | M27689 | |
| Pathway | REACTOME_PYRIMIDINE_SALVAGE | 8.11e-05 | 11 | 114 | 3 | MM15422 | |
| Pathway | KEGG_TIGHT_JUNCTION | 9.64e-05 | 132 | 114 | 7 | M11355 | |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 1.08e-04 | 31 | 114 | 4 | M877 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 2.42e-04 | 38 | 114 | 4 | MM14969 | |
| Pathway | KEGG_VIRAL_MYOCARDITIS | 2.52e-04 | 70 | 114 | 5 | M12294 | |
| Pathway | REACTOME_ACETYLCHOLINE_NEUROTRANSMITTER_RELEASE_CYCLE | 3.22e-04 | 17 | 114 | 3 | M93 | |
| Pathway | REACTOME_ACETYLCHOLINE_NEUROTRANSMITTER_RELEASE_CYCLE | 3.22e-04 | 17 | 114 | 3 | MM14907 | |
| Pathway | REACTOME_NOREPINEPHRINE_NEUROTRANSMITTER_RELEASE_CYCLE | 3.85e-04 | 18 | 114 | 3 | M13015 | |
| Pathway | REACTOME_SEROTONIN_NEUROTRANSMITTER_RELEASE_CYCLE | 3.85e-04 | 18 | 114 | 3 | MM14702 | |
| Pathway | REACTOME_NOREPINEPHRINE_NEUROTRANSMITTER_RELEASE_CYCLE | 3.85e-04 | 18 | 114 | 3 | MM14703 | |
| Pathway | REACTOME_SEROTONIN_NEUROTRANSMITTER_RELEASE_CYCLE | 3.85e-04 | 18 | 114 | 3 | M27043 | |
| Pathway | WP_PROGERIAASSOCIATED_LIPODYSTROPHY | 7.09e-04 | 22 | 114 | 3 | M42534 | |
| Pathway | BIOCARTA_CASPASE_PATHWAY | 7.09e-04 | 22 | 114 | 3 | M17902 | |
| Pathway | REACTOME_NUCLEOTIDE_SALVAGE | 8.11e-04 | 23 | 114 | 3 | MM15552 | |
| Pathway | REACTOME_DOPAMINE_NEUROTRANSMITTER_RELEASE_CYCLE | 8.11e-04 | 23 | 114 | 3 | MM14852 | |
| Pathway | REACTOME_NUCLEOTIDE_SALVAGE | 8.11e-04 | 23 | 114 | 3 | M27831 | |
| Pathway | REACTOME_DOPAMINE_NEUROTRANSMITTER_RELEASE_CYCLE | 8.11e-04 | 23 | 114 | 3 | M12627 | |
| Pathway | REACTOME_GLUTAMATE_NEUROTRANSMITTER_RELEASE_CYCLE | 9.21e-04 | 24 | 114 | 3 | MM14834 | |
| Pathway | REACTOME_GLUTAMATE_NEUROTRANSMITTER_RELEASE_CYCLE | 9.21e-04 | 24 | 114 | 3 | M630 | |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | DLG5 MYO6 SPTBN1 ARHGEF18 CCDC187 PLEKHG2 PLEKHG4B LMNB1 MAP3K11 AKAP13 SPEN | 1.04e-03 | 450 | 114 | 11 | M27078 |
| Pathway | BIOCARTA_CASPASE_PATHWAY | 1.04e-03 | 25 | 114 | 3 | MM1359 | |
| Pathway | BIOCARTA_HIVNEF_PATHWAY | 1.08e-03 | 56 | 114 | 4 | M13968 | |
| Pathway | BIOCARTA_IRES_PATHWAY | 1.33e-03 | 7 | 114 | 2 | M22028 | |
| Pathway | REACTOME_LOSS_OF_MECP2_BINDING_ABILITY_TO_THE_NCOR_SMRT_COMPLEX | 1.33e-03 | 7 | 114 | 2 | M27899 | |
| Pathway | REACTOME_COPI_MEDIATED_ANTEROGRADE_TRANSPORT | 1.41e-03 | 102 | 114 | 5 | M27648 | |
| Pathway | BIOCARTA_TNFR1_PATHWAY | 1.46e-03 | 28 | 114 | 3 | MM1516 | |
| Pathway | BIOCARTA_FAS_PATHWAY | 1.46e-03 | 28 | 114 | 3 | MM1396 | |
| Pathway | REACTOME_HDMS_DEMETHYLATE_HISTONES | 1.61e-03 | 29 | 114 | 3 | MM14934 | |
| Pathway | BIOCARTA_TNFR1_PATHWAY | 1.61e-03 | 29 | 114 | 3 | M3618 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 1.67e-03 | 63 | 114 | 4 | M11187 | |
| Pathway | WP_FAMILIAL_PARTIAL_LIPODYSTROPHY | 1.78e-03 | 30 | 114 | 3 | M42537 | |
| Pathway | BIOCARTA_FAS_PATHWAY | 1.78e-03 | 30 | 114 | 3 | M9503 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 1.78e-03 | 30 | 114 | 3 | M27216 | |
| Pubmed | SMG1 MYH2 MAP9 MYH7 MYH13 CALD1 KRT18 PPFIA2 PPP1R12B PPFIA1 DZIP1L SPTBN1 CNTRL NOL6 UTP14A ASH1L NUMA1 ATP10B ZNF318 LMNB2 ZFC3H1 ODF2 PPL KRT73 SPTBN4 NCOR1 MYPOP LMNA LMNB1 MYH14 PRRC2C RBMX2 EIF4G1 CCAR2 GNA12 EIF3A PLEC UQCRH SPEN DYNC1I1 | 2.23e-19 | 1442 | 170 | 40 | 35575683 | |
| Pubmed | DMXL2 SHROOM3 PPFIA1 SPTBN1 NUMA1 ARHGEF18 DAPK1 CHD8 ZNF318 LMNB2 KANK2 CCDC177 SPTBN4 NCOR1 NCOR2 ABLIM1 LMNB1 SYNJ1 UBR5 WTIP ZC3H4 PRRC2C EIF4G1 TJAP1 PLEKHA5 CCAR2 MTCL1 GOLGA1 | 3.47e-14 | 963 | 170 | 28 | 28671696 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | KDM5C ZC3H13 SPTBN1 NUMA1 ZNF318 ODF2 PPL SCAF4 PAPOLG NCOR1 NCOR2 ABLIM1 PWWP2B LMNA ZC3H4 RBMX2 BRD4 FHOD1 EIF4G1 TJAP1 CCAR2 RERE PLEC SPEN SNRNP200 | 9.24e-14 | 774 | 170 | 25 | 15302935 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | SHROOM3 ATP13A1 LAMB3 AMBRA1 CHD8 LMNB2 ATG2A CNTROB DENND1A NCOR1 NCOR2 PWWP2B SYNJ1 UCKL1 BRD4 EIF4G1 SNX8 ANKRD11 MAP3K11 AKAP13 GNA12 KIFC3 PLEC GNAZ SPEN AHNAK2 RAB11FIP3 | 5.95e-12 | 1105 | 170 | 27 | 35748872 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | CUL4A SHROOM3 CALD1 MYO6 PPFIA2 SPTB ASH1L ARHGEF18 CHCHD6 DENND1A MAP3K12 SPTBN4 PLEKHG4B PARP10 NCOR2 ABLIM1 PWWP2B COQ8A MYH14 UCKL1 LRRC27 ANKRD11 KNDC1 TJAP1 AKAP13 KATNIP KDM2A ANKRD24 RERE GNAZ CROCC | 8.11e-12 | 1489 | 170 | 31 | 28611215 |
| Pubmed | KDM5C SPTBN1 NUMA1 LAMC1 CHD8 CNTROB LMNA ZC3H4 PRRC2C EIF4G1 SNX8 ANKRD11 KDM2A MTCL1 PLEC AHNAK2 | 9.88e-12 | 332 | 170 | 16 | 37433992 | |
| Pubmed | MAP9 DMXL2 CALD1 MYO6 PPFIA2 PPP1R12B PPFIA1 SPTB SPTBN1 DAPK1 MAP7 KANK2 CCDC177 SPTBN4 ABLIM1 CSE1L LMNA SYNJ1 MYH14 PRRC2C EIF4G1 KNDC1 PLEKHA5 EIF3A PLEC GNAZ CROCC SNRNP200 DYNC1I1 PPP1R12C | 1.56e-11 | 1431 | 170 | 30 | 37142655 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | ABCF3 RNF31 KRT18 MYO6 DHX40 SPTBN1 NOL6 UTP14A NUMA1 AMBRA1 CHCHD6 CHD8 LMNB2 NCOR2 CSE1L LMNA LMNB1 UBR5 MYH14 FHOD1 EIF4G1 PLEKHA5 CCAR2 AKAP13 KDM2A EIF3A PLEC SNRNP200 AHNAK2 | 2.11e-11 | 1353 | 170 | 29 | 29467282 |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | ANKRD35 TNIP2 ZC3H13 ZFC3H1 MAP7 KANK2 SPTBN4 LMNA LMNB1 PRRC2C EIF4G1 PLEKHA5 AKAP13 EIF3A MTCL1 SPEN | 3.44e-11 | 361 | 170 | 16 | 26167880 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | CUL4A DLG5 SHROOM3 KRT18 PPFIA1 SPTBN1 LAMC1 PLEKHG2 MAP7 DENND1A ABLIM1 SYNJ1 PRRC2C BRD4 EIF4G1 ANKRD11 PLEKHA5 AKAP13 MTCL1 PLEC PPP1R12C CCDC102A AHNAK2 | 4.46e-11 | 861 | 170 | 23 | 36931259 |
| Pubmed | Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. | DLG5 CEP85 UTP14A ARHGEF18 ZNF318 CNTROB NCOR1 NCOR2 UBR5 CCAR2 SPEN CCDC102A | 1.32e-10 | 184 | 170 | 12 | 32908313 |
| Pubmed | DLG5 ZC3H13 SPTB LMNB2 ZFC3H1 SPTBN5 MYH14 TEKT1 EIF3A KIFC3 PLEC CROCC | 1.60e-10 | 187 | 170 | 12 | 26460568 | |
| Pubmed | DLG5 SHROOM3 BMP2K ATP13A1 DHX40 PPP1R12B PPFIA1 NOL6 UTP14A CHD8 ZNF318 ZFC3H1 MAP7 ODF2 ANKZF1 KANK2 DENND1A SCAF4 ABLIM1 MICALL2 SUN2 RBMX2 EIF4G1 ANKRD11 EIF3A CROCC EPN1 SPEN PPP1R12C | 2.28e-10 | 1497 | 170 | 29 | 31527615 | |
| Pubmed | CALD1 KRT18 SPTB SPTBN1 NUMA1 LMNB2 PPL SCAF4 LMNA PRRC2C EIF4G1 PLEKHA5 KDM2A PLEC AHNAK2 | 3.41e-10 | 360 | 170 | 15 | 33111431 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | DLG5 KRT18 MYO6 ZC3H13 SPTBN1 NOL6 UTP14A NUMA1 LAMB3 LMNB2 ZFC3H1 MAP7 PPL ABLIM1 CSE1L LMNA LMNB1 PRRC2C SUN2 FHOD1 EIF4G1 PLEKHA5 EIF3A PLEC SPEN SNRNP200 | 5.55e-10 | 1257 | 170 | 26 | 36526897 |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | ABCF3 CALD1 KRT18 MYO6 CHD8 ZNF318 PAPOLG NCOR1 NCOR2 ABLIM1 LMNA MYH14 FHOD1 EIF4G1 CCDC102A AHNAK2 | 7.10e-10 | 444 | 170 | 16 | 34795231 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | CALD1 KRT18 NOL6 UTP14A NUMA1 LAMC1 ZNF318 LMNB2 SCAF4 ABLIM1 CSE1L LMNA LMNB1 UBR5 MYH14 ZC3H4 EIF4G1 UCK2 CCAR2 EIF3A PLEC SPEN SNRNP200 | 1.29e-09 | 1024 | 170 | 23 | 24711643 |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | CUL4A DLG5 CALD1 KRT18 BMP2K MYO6 RRP7BP PPP1R12B SPTBN1 NOL6 UTP14A NUMA1 MAP7 ABLIM1 CSE1L LMNA LMNB1 MYH14 RBMX2 EIF3A PLEC SNRNP200 | 1.71e-09 | 949 | 170 | 22 | 36574265 |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | CUL4A CALD1 KRT18 ZC3H13 NOL6 UTP14A NUMA1 CHD8 ZNF318 SCAF4 NCOR1 NCOR2 LMNA LMNB1 ZC3H4 PRRC2C BRD4 EIF4G1 ANKRD11 UQCRH SPEN SNRNP200 | 1.88e-09 | 954 | 170 | 22 | 36373674 |
| Pubmed | CEP85 CALD1 NUMA1 CHD8 ZNF318 SCAF4 CCDC43 NCOR1 ABLIM1 LMNB1 SYNJ1 PRRC2C BRD4 PLEKHA5 KDM2A SPEN SNRNP200 | 2.02e-09 | 549 | 170 | 17 | 38280479 | |
| Pubmed | SMG1 MYH2 CALD1 KRT18 BMP2K SPTBN1 NOL6 NUMA1 LAMC1 MAP7 DENND1A STX12 ABLIM1 CSE1L LMNA COQ8A UBR5 PRRC2C SUN2 EIF4G1 CCAR2 EIF3A SNAP25 UQCRH EPN1 SNRNP200 AHNAK2 | 2.08e-09 | 1440 | 170 | 27 | 30833792 | |
| Pubmed | Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer. | SMG1 MYH2 MYH7 SHROOM3 CALD1 KRT18 MYO6 SPTB SPTBN1 NUMA1 ABLIM1 LMNA LMNB1 MYH14 EIF4G1 PLEC SNRNP200 PPP1R12C | 2.11e-09 | 626 | 170 | 18 | 33644029 |
| Pubmed | KRT18 MYO6 SPTBN1 CNTRL CHD8 ABLIM1 CSE1L FHOD1 MAP3K11 PLEKHA5 AKAP13 KDM2A ANKRD24 EIF3A PLEC SNRNP200 | 2.59e-09 | 486 | 170 | 16 | 20936779 | |
| Pubmed | 2.68e-09 | 46 | 170 | 7 | 30419336 | ||
| Pubmed | SMG1 DMXL2 CEP85 RNF31 DHX40 NOL6 UTP14A LAMB3 AMBRA1 GPAM CHD8 ANKZF1 COQ8A ZC3H4 PRRC2C PLEKHA5 AKAP13 EPN1 | 3.80e-09 | 650 | 170 | 18 | 38777146 | |
| Pubmed | ZC3H13 SPTBN1 NOL6 UTP14A NUMA1 CHD8 ZNF318 LMNB2 CSE1L LMNA UBR5 MYH14 PRRC2C EIF4G1 CCAR2 PLEC SPEN SNRNP200 | 4.08e-09 | 653 | 170 | 18 | 22586326 | |
| Pubmed | KDM5C ZC3H13 NUMA1 CHD8 MAP7 ANKZF1 NCOR1 LMNA ZC3H4 UCKL1 EIF4G1 MAP3K11 PLEKHA5 AKAP13 MTCL1 SPEN | 4.22e-09 | 503 | 170 | 16 | 16964243 | |
| Pubmed | 7.29e-09 | 118 | 170 | 9 | 30979931 | ||
| Pubmed | DCHS2 DMXL2 CEP85 MYO6 ATP13A1 SPTB SPTBN1 ASH1L ZFC3H1 BTBD1 ODF2 KANK2 SPTBN4 ABLIM1 SYNJ1 MYH14 EIF4G1 MAP3K11 ANKRD24 SNAP25 KIFC3 PLEC SNRNP200 DYNC1I1 | 1.94e-08 | 1285 | 170 | 24 | 35914814 | |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | DLG5 SHROOM3 ABCF3 CALD1 KRT18 MYO6 SPTBN1 KANK2 PPL CCDC43 ABLIM1 SYNJ1 EIF4G1 PLEKHA5 SNAP25 PLEC | 2.14e-08 | 565 | 170 | 16 | 25468996 |
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | MYH2 MYH7 MYH13 KRT18 PPP2R2D MYO6 SPTBN1 LAMB3 LMNB2 LMNA LMNB1 UBR5 MYH14 PRRC2C CCAR2 EIF3A PLEC | 2.27e-08 | 647 | 170 | 17 | 26618866 |
| Pubmed | CUL4A RNF31 KDM5C PPFIA1 ASH1L AMBRA1 CHD8 ZNF318 CRACR2B MAP7 KANK2 NCOR2 PWWP2B COQ8A UBR5 ZC3H4 SUN2 UCKL1 BRD4 TEKT1 UCK2 RERE | 3.13e-08 | 1116 | 170 | 22 | 31753913 | |
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | CCHCR1 MAP9 MYO6 ATP13A1 PPP1R12B CNTRL NOL6 ZNF318 MAP7 CCDC51 KANK2 ABLIM1 UBR5 MYH14 SUN2 BRD4 PLEKHA5 EIF3A | 3.67e-08 | 754 | 170 | 18 | 33060197 |
| Pubmed | SHROOM3 RNF31 PPP2R2D MYO6 TNIP2 LAMC1 BTBD1 MAP7 ANKZF1 KANK2 PARP10 NCOR2 COQ8A UBR5 KIFC3 EPN1 | 5.37e-08 | 604 | 170 | 16 | 38803224 | |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | KRT18 ZC3H13 SPTBN1 NOL6 UTP14A NUMA1 KRT73 CSE1L LMNA LMNB1 PRRC2C EIF4G1 CCAR2 EIF3A SPEN SNRNP200 | 5.49e-08 | 605 | 170 | 16 | 28977666 |
| Pubmed | SHROOM3 MYH13 BMP2K MYO6 PPFIA1 CNTRL NOL6 UTP14A ZNF318 PPL NCOR1 LMNB1 UBR5 ZC3H4 TJAP1 CCAR2 SPEN SNRNP200 | 5.76e-08 | 777 | 170 | 18 | 35844135 | |
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | DLG5 KRT18 ZNF318 MAP7 KANK2 PRRC2C EIF4G1 PLEKHA5 PLEC SNRNP200 AHNAK2 | 6.11e-08 | 256 | 170 | 11 | 33397691 |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | MYO6 NUMA1 LAMC1 MYH14 ZC3H4 PRRC2C EIF4G1 AKAP13 PLEC SNRNP200 | 6.62e-08 | 202 | 170 | 10 | 33005030 |
| Pubmed | ALS/FTD-causing mutation in cyclin F causes the dysregulation of SFPQ. | MYO6 SPTBN1 NOL6 UTP14A NUMA1 AMBRA1 MARCHF7 CHD8 ZNF318 LMNB2 NCOR1 CSE1L MYH14 PRRC2C UCKL1 CCAR2 | 8.36e-08 | 624 | 170 | 16 | 33729478 |
| Pubmed | 9.53e-08 | 210 | 170 | 10 | 16565220 | ||
| Pubmed | DLG5 CEP85 DHX40 NOL6 CHD8 KANK2 KRT73 SCAF4 ABLIM1 LMNB1 ZC3H4 FHOD1 PLEKHA5 KDM2A | 9.64e-08 | 472 | 170 | 14 | 38943005 | |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | KDM5C SPTBN1 NUMA1 CHD8 NCOR1 CSE1L LMNA EIF4G1 CCAR2 PLEC SNRNP200 AHNAK2 | 9.99e-08 | 332 | 170 | 12 | 32786267 |
| Pubmed | Nesprin 1α2 is essential for mouse postnatal viability and nuclear positioning in skeletal muscle. | 1.13e-07 | 10 | 170 | 4 | 28533284 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | CEP85 ABCF3 CALD1 BMP2K MYO6 PPFIA1 UTP14A ZFC3H1 MYH14 ZC3H4 PRRC2C EIF4G1 AKAP13 KDM2A PLEC SPEN AHNAK2 | 1.14e-07 | 724 | 170 | 17 | 36232890 |
| Pubmed | 1.15e-07 | 3 | 170 | 3 | 11294830 | ||
| Pubmed | 1.15e-07 | 3 | 170 | 3 | 25312645 | ||
| Pubmed | A- and B-type lamins are differentially expressed in normal human tissues. | 1.15e-07 | 3 | 170 | 3 | 9243284 | |
| Pubmed | 1.15e-07 | 3 | 170 | 3 | 15284226 | ||
| Pubmed | β spectrin-dependent and domain specific mechanisms for Na+ channel clustering. | 1.15e-07 | 3 | 170 | 3 | 32425157 | |
| Pubmed | Review: nuclear lamins--structural proteins with fundamental functions. | 1.15e-07 | 3 | 170 | 3 | 10806082 | |
| Pubmed | 1.15e-07 | 3 | 170 | 3 | 28241138 | ||
| Pubmed | Expression of nuclear lamins during mouse preimplantation development. | 1.15e-07 | 3 | 170 | 3 | 3046911 | |
| Pubmed | 1.15e-07 | 3 | 170 | 3 | 10960149 | ||
| Pubmed | 1.15e-07 | 3 | 170 | 3 | 20004208 | ||
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | KRT18 BMP2K SPTBN1 NOL6 LAMB3 LAMC1 CHD8 LMNB2 ZFC3H1 STX12 NCOR2 ABLIM1 CSE1L LMNA LMNB1 SUN2 BRD4 FHOD1 EIF4G1 RERE PLEC SNRNP200 | 1.15e-07 | 1203 | 170 | 22 | 29180619 |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | CUL4A ABCF3 KRT18 SPTBN1 UTP14A NUMA1 MAP7 CCDC51 ANKZF1 CSE1L LMNA UBR5 ZC3H4 PRRC2C FHOD1 EIF4G1 UCK2 CCAR2 AKAP13 EIF3A MTCL1 PLEC SNRNP200 AHNAK2 | 1.17e-07 | 1415 | 170 | 24 | 28515276 |
| Pubmed | Biochemical Reduction of the Topology of the Diverse WDR76 Protein Interactome. | KRT18 SPTBN1 NUMA1 LAMC1 CHD8 CSE1L LMNA LMNB1 PLEC SNRNP200 | 1.41e-07 | 219 | 170 | 10 | 31353912 |
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | DMXL2 PPFIA2 PPFIA1 SPTBN1 ARHGEF18 CHCHD6 ABLIM1 SYNJ1 UBR5 GNAZ DYNC1I1 | 1.56e-07 | 281 | 170 | 11 | 28706196 |
| Pubmed | SMG1 DMXL2 MYH7 SPTB SPTBN1 LAMC1 BTBD1 NCOR1 ABLIM1 LMNA MYH14 KDM2A EIF3A PLEC | 1.81e-07 | 497 | 170 | 14 | 23414517 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | DCHS2 MYH13 MYO6 KDM5C PPFIA1 SPTBN1 NUMA1 CCDC187 SCAF4 ZC3H4 CROCC2 ANKRD11 PLEKHA5 GOLGA1 | 1.81e-07 | 497 | 170 | 14 | 36774506 |
| Pubmed | SMG1 DMXL2 CHD8 ABLIM1 SYNJ1 UBR5 ZC3H4 PLEKHA5 KDM2A SNRNP200 | 1.81e-07 | 225 | 170 | 10 | 12168954 | |
| Pubmed | A function for cyclin D1 in DNA repair uncovered by protein interactome analyses in human cancers. | 2.00e-07 | 125 | 170 | 8 | 21654808 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | SHROOM3 ABCF3 PPFIA1 SPTBN1 CHD8 SNUPN MAP7 NCOR2 CSE1L LMNA BRD4 FHOD1 MTCL1 PLEC SNRNP200 | 2.02e-07 | 582 | 170 | 15 | 20467437 |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | SHROOM3 NUMA1 ARHGEF18 ATG2A KDM5D PLEKHG4B NCOR1 NCOR2 LMNA AKAP13 PLEC EPN1 SPEN | 2.26e-07 | 430 | 170 | 13 | 35044719 |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | CCHCR1 DLG5 SHROOM3 CALD1 BMP2K DHX40 CNTRL PLEKHG2 ATG2A ODF2 KANK2 CCDC43 NCOR1 LMNB1 SYNJ1 UBR5 PLEC DYNC1I1 | 2.29e-07 | 853 | 170 | 18 | 28718761 |
| Pubmed | Novel interactors and a role for supervillin in early cytokinesis. | 2.36e-07 | 28 | 170 | 5 | 20309963 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | TCF4 MYH7 ABCF3 PPP2R2D TNIP2 KDM5C UTP14A LMNB2 KANK2 NCOR1 NCOR2 UBR5 PRRC2C EIF4G1 CCAR2 KDM2A SPEN SNRNP200 | 2.45e-07 | 857 | 170 | 18 | 25609649 |
| Pubmed | Ubiquitin-Independent Disassembly by a p97 AAA-ATPase Complex Drives PP1 Holoenzyme Formation. | KRT18 MYO6 ZC3H13 PPP1R12B SPTBN1 NUMA1 ZNF318 ZFC3H1 ZC3H4 AKAP13 PLEC PPP1R12C | 2.46e-07 | 361 | 170 | 12 | 30344098 |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | CUL4A CALD1 PPP2R2D PPP1R12B NUMA1 AMBRA1 CHCHD6 KANK2 PPL LMNB1 MICALL2 UBR5 ZC3H4 RBMX2 EIF4G1 CCAR2 EIF3A MTCL1 KIFC3 SNRNP200 PPP1R12C | 2.52e-07 | 1155 | 170 | 21 | 20360068 |
| Pubmed | 3.81e-07 | 13 | 170 | 4 | 18796539 | ||
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | DLG5 DMXL2 ARRDC5 ZC3H13 SPTBN1 UTP14A LMNB2 SCAF4 CSE1L LMNA LMNB1 ZC3H4 SUN2 RBMX2 BRD4 EIF4G1 GNA12 PLEC SPEN SNRNP200 | 3.85e-07 | 1082 | 170 | 20 | 38697112 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | CUL4A KRT18 ZC3H13 NUMA1 ZNF318 LMNB2 ZFC3H1 MAP7 SCAF4 NCOR1 NCOR2 MYPOP LMNA LMNB1 SUN2 RBMX2 BRD4 ANKRD11 KDM2A UQCRH SPEN SNRNP200 | 3.98e-07 | 1294 | 170 | 22 | 30804502 |
| Pubmed | Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette. | TCF4 SHROOM3 CEP85 MAP7 ODF2 SCAF4 NCOR1 NCOR2 RCC1L SUN2 ANKRD11 PLEKHA5 RERE KIFC3 | 4.47e-07 | 536 | 170 | 14 | 15840001 |
| Pubmed | 4.57e-07 | 4 | 170 | 3 | 18632669 | ||
| Pubmed | 4.57e-07 | 4 | 170 | 3 | 2680424 | ||
| Pubmed | 4.57e-07 | 4 | 170 | 3 | 30968547 | ||
| Pubmed | TCF4 SHROOM3 CEP85 MAP7 ODF2 SCAF4 NCOR1 NCOR2 RCC1L SUN2 ANKRD11 PLEKHA5 RERE KIFC3 | 4.68e-07 | 538 | 170 | 14 | 10512203 | |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | PPP2R2D SPTBN1 CNTRL ASH1L NUMA1 DAPK1 CHD8 CSE1L LMNA LMNB1 MYH14 EIF4G1 AKAP13 EIF3A PLEC SNRNP200 AHNAK2 | 5.17e-07 | 807 | 170 | 17 | 30575818 |
| Pubmed | Mechanical regulation of glycolysis via cytoskeleton architecture. | 5.31e-07 | 14 | 170 | 4 | 32051585 | |
| Pubmed | SMG1 TCF4 CEP85 MYO6 DHX40 TNIP2 SPTBN1 UTP14A NUMA1 CHD8 ZNF318 MAP7 SCAF4 NCOR1 NCOR2 CSE1L MYH14 PRRC2C EIF4G1 CCAR2 EIF3A RERE SPEN | 5.47e-07 | 1429 | 170 | 23 | 35140242 | |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | CUL4A MYH2 KRT18 PPP2R2D MYO6 DHX40 NOL6 ADGRB1 AMBRA1 ATG2A BTBD1 CSE1L UBR5 SUN2 EIF4G1 EIF3A MTCL1 PLEC SNRNP200 | 5.49e-07 | 1005 | 170 | 19 | 19615732 |
| Pubmed | CDK7/GRP78 signaling axis contributes to tumor growth and metastasis in osteosarcoma. | CALD1 KRT18 MYO6 DZIP1L SPTBN1 CNTRL CSE1L LMNB1 SUN2 ANKRD11 MTCL1 PLEC SPEN | 5.89e-07 | 468 | 170 | 13 | 36042349 |
| Pubmed | SMG1 MYH2 PLVAP MYO6 RRP7BP DHX40 NOL6 LAMC1 NCOR1 NCOR2 COQ8A MTCL1 UQCRH SPEN AHNAK2 | 6.45e-07 | 638 | 170 | 15 | 31182584 | |
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | SHROOM3 MYO6 ZC3H13 SPTBN1 NUMA1 LMNB2 CSE1L LMNA LMNB1 FHOD1 EIF3A PLEC SNRNP200 | 7.29e-07 | 477 | 170 | 13 | 31300519 |
| Pubmed | Protein interactome reveals converging molecular pathways among autism disorders. | ANKRD35 KRT18 VMAC TNIP2 PPFIA2 CNTRL LAMC1 CNTROB SPTBN4 TJAP1 CCAR2 ANKRD24 EIF3A PPP1R12C | 7.52e-07 | 560 | 170 | 14 | 21653829 |
| Pubmed | Histone methyltransferase DOT1L coordinates AR and MYC stability in prostate cancer. | RNF31 KRT18 MYO6 CCDC51 NCOR1 CSE1L LMNB1 UBR5 MYH14 SNRNP200 | 7.84e-07 | 264 | 170 | 10 | 32814769 |
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | CEP85 BMP2K TNIP2 UTP14A MARCHF7 SNUPN ATG2A ANKZF1 KANK2 CNTROB DENND1A ABLIM1 UBR5 KNDC1 TJAP1 PLEKHA5 CCAR2 KATNIP EPN1 | 8.88e-07 | 1038 | 170 | 19 | 26673895 |
| Pubmed | CALD1 ATP13A1 SPTBN1 NUMA1 LMNB2 LYSMD3 CCDC43 LMNA LMNB1 UBR5 PRRC2C EIF4G1 CROCC AHNAK2 | 8.89e-07 | 568 | 170 | 14 | 37774976 | |
| Pubmed | ISG15 Connects Autophagy and IFN-γ-Dependent Control of Toxoplasma gondii Infection in Human Cells. | BMP2K MYO6 ATP13A1 CSE1L LMNA PRRC2C EIF4G1 PLEC SNRNP200 AHNAK2 | 8.98e-07 | 268 | 170 | 10 | 33024031 |
| Pubmed | 9.83e-07 | 209 | 170 | 9 | 36779422 | ||
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | 9.93e-07 | 271 | 170 | 10 | 32433965 | |
| Pubmed | ZNF212 promotes genomic integrity through direct interaction with TRAIP. | 1.01e-06 | 37 | 170 | 5 | 36594163 | |
| Pubmed | TRIM15 MYH7 SHROOM3 VMAC SPTBN1 CNTRL NOL6 LENG1 LMNB2 KANK2 CNTROB CCDC43 NCOR2 UBR5 EIF4G1 SNRNP200 | 1.03e-06 | 754 | 170 | 16 | 35906200 | |
| Pubmed | DLG5 CEP85 MYH13 MYO6 ATP13A1 PPFIA1 SPTBN1 NOL6 NUMA1 LAMC1 ANKZF1 DENND1A SCAF4 RCC1L CSE1L LMNB1 COQ8A MYH14 PRRC2C RBMX2 EIF4G1 PLEC | 1.04e-06 | 1371 | 170 | 22 | 36244648 | |
| Pubmed | DMXL2 MYO6 ATP13A1 UTP14A ARHGEF18 GPAM ZFC3H1 SCAF4 SUN2 KDM2A ANKRD24 EIF3A SNRNP200 | 1.05e-06 | 493 | 170 | 13 | 15368895 | |
| Pubmed | DLG5 DMXL2 SHROOM3 MYO6 ATP13A1 ZC3H13 PPFIA1 SPTBN1 UTP14A LAMC1 CHCHD6 LMNB2 ZFC3H1 MAP7 KANK2 LMNA LMNB1 UBR5 SUN2 ANKRD11 PLEKHA5 AKAP13 SNRNP200 | 1.08e-06 | 1487 | 170 | 23 | 33957083 | |
| Pubmed | 1.14e-06 | 5 | 170 | 3 | 23374351 | ||
| Pubmed | Reciprocal knock-in mice to investigate the functional redundancy of lamin B1 and lamin B2. | 1.14e-06 | 5 | 170 | 3 | 24672053 | |
| Pubmed | PPFIA1 LAMC1 CHD8 ZNF318 NCOR1 NCOR2 SYNJ1 UBR5 BRD4 PLEKHA5 RERE PLEC | 1.15e-06 | 418 | 170 | 12 | 34709266 | |
| Pubmed | SMG1 MYO6 SPTBN1 ASH1L LAMC1 PPL NCOR1 NCOR2 UBR5 BRD4 EIF4G1 KDM2A PLEC EPN1 | 1.42e-06 | 591 | 170 | 14 | 15231748 | |
| Interaction | KIF20A interactions | ANKRD35 SHROOM3 MYO6 TNIP2 SPTB SPTBN1 NOL6 NUMA1 AMBRA1 CHCHD6 CHD8 ZNF318 LMNB2 MAP7 DDIT3 PPL SPTBN4 ABLIM1 LMNA LMNB1 UBR5 MYH14 BRD4 ANKRD18A EIF3A KIFC3 PLEC EPN1 SNRNP200 PPP1R12C AHNAK2 | 5.26e-10 | 1052 | 166 | 31 | int:KIF20A |
| Interaction | NUP43 interactions | CUL4A KDM5C ZC3H13 NOL6 ASH1L CHD8 ZNF318 ZFC3H1 NCOR1 NCOR2 LMNA LMNB1 UBR5 PRRC2C RBMX2 EIF4G1 ANKRD11 CCAR2 KDM2A RERE SPEN SNRNP200 AHNAK2 | 1.92e-09 | 625 | 166 | 23 | int:NUP43 |
| Interaction | TRIM37 interactions | MYH2 DLG5 MYH7 CEP85 MYH13 KRT18 MYO6 DZIP1L SPTBN1 UTP14A ARHGEF18 ZNF318 CNTROB NCOR1 NCOR2 LMNA UBR5 MYH14 ANKRD11 CCAR2 PLEC SPEN CCDC102A | 2.24e-09 | 630 | 166 | 23 | int:TRIM37 |
| Interaction | KRT19 interactions | CCHCR1 DLG5 CEP85 RNF31 KRT18 TNIP2 LENG1 KANK2 CNTROB KRT73 LMNB1 PLEKHA5 KIFC3 PLEC DYNC1I1 | 1.28e-08 | 282 | 166 | 15 | int:KRT19 |
| Interaction | EED interactions | CUL4A SHROOM3 ABCF3 KRT18 BMP2K MYO6 ZC3H13 SPTBN1 NOL6 UTP14A NUMA1 LAMC1 DAPK1 GPAM LMNB2 SCAF4 NCOR1 ABLIM1 CSE1L LMNA LMNB1 SYNJ1 SUN2 BRD4 EIF4G1 SNX8 CCAR2 KDM2A EIF3A PLEC CROCC EPN1 SPEN SNRNP200 | 2.13e-08 | 1445 | 166 | 34 | int:EED |
| Interaction | TFIP11 interactions | CCHCR1 DHX40 TNIP2 LENG1 UTP14A CCDC187 LMNB2 KANK2 LMNA COQ8A UBR5 ANKRD11 EIF3A KIFC3 SPEN SNRNP200 GOLGA1 | 9.42e-08 | 427 | 166 | 17 | int:TFIP11 |
| Interaction | MEX3A interactions | KDM5C SPTBN1 NUMA1 LAMC1 CHD8 CNTROB LMNA ZC3H4 PRRC2C EIF4G1 SNX8 ANKRD11 KDM2A MTCL1 PLEC AHNAK2 | 1.24e-07 | 384 | 166 | 16 | int:MEX3A |
| Interaction | LATS1 interactions | CUL4A MYH2 DLG5 MYH7 CEP85 MYH13 WWC3 SPTBN1 CNTROB KRT73 LMNA WTIP MYH14 SUN2 MAP3K11 PLEKHA5 PLEC | 1.45e-07 | 440 | 166 | 17 | int:LATS1 |
| Interaction | DHX40 interactions | DHX40 ZC3H13 UTP14A ZNF318 LMNB2 ZFC3H1 LMNA LMNB1 UBR5 ZC3H4 BRD4 ANKRD11 SNRNP200 | 1.55e-07 | 249 | 166 | 13 | int:DHX40 |
| Interaction | SNAPIN interactions | SMG1 MYH7 SPTB SPTBN1 LAMC1 KANK2 MYPOP LMNB1 MYH14 SNAP25 PLEC | 1.60e-07 | 169 | 166 | 11 | int:SNAPIN |
| Interaction | GAN interactions | DLG5 ZC3H13 SPTB LMNB2 ZFC3H1 KRT73 SPTBN5 MYH14 TEKT1 EIF3A KIFC3 PLEC CROCC | 1.86e-07 | 253 | 166 | 13 | int:GAN |
| Interaction | SNRNP40 interactions | CUL4A ZC3H13 NOL6 NUMA1 ZNF318 ZFC3H1 SCAF4 PAPOLG NCOR1 NCOR2 YJU2 LMNA LMNB1 UBR5 ZC3H4 BRD4 CCAR2 KDM2A SPEN SNRNP200 | 3.12e-07 | 637 | 166 | 20 | int:SNRNP40 |
| Interaction | SBDS interactions | MYH2 MYH7 MYH13 TNIP2 SPTBN5 LMNA BRD4 EIF3A MTCL1 PLEC SNRNP200 | 3.19e-07 | 181 | 166 | 11 | int:SBDS |
| Interaction | ARL16 interactions | 4.18e-07 | 83 | 166 | 8 | int:ARL16 | |
| Interaction | SEC16A interactions | CUL4A CEP85 RNF31 KRT18 BMP2K MYO6 TNIP2 AMBRA1 MAP7 KANK2 NCOR2 LMNA PRRC2C PLEKHA5 CCAR2 GOLGA1 | 5.00e-07 | 426 | 166 | 16 | int:SEC16A |
| Interaction | PML interactions | ABCF3 CALD1 KRT18 MYO6 NUMA1 CHCHD6 CHD8 ZNF318 CCDC51 PAPOLG NCOR1 NCOR2 ABLIM1 CSE1L LMNA LMNB1 UBR5 MYH14 BRD4 FHOD1 EIF4G1 EIF3A CCDC102A AHNAK2 | 7.16e-07 | 933 | 166 | 24 | int:PML |
| Interaction | KIAA0753 interactions | CCHCR1 KRT18 MYO6 CNTRL MAP7 ODF2 ABLIM1 PLEKHA5 KIFC3 GOLGA1 | 7.25e-07 | 157 | 166 | 10 | int:KIAA0753 |
| Interaction | CCND1 interactions | KRT18 NUMA1 AMBRA1 LMNB2 NCOR1 NCOR2 CSE1L LMNA LMNB1 BRD4 FHOD1 CCAR2 KDM2A | 7.51e-07 | 286 | 166 | 13 | int:CCND1 |
| Interaction | SNW1 interactions | TRIM15 SHROOM3 ABCF3 DHX40 TNIP2 SPTBN1 CHD8 SNUPN ODF2 KANK2 NCOR1 NCOR2 YJU2 CSE1L LMNA LMNB1 UBR5 BRD4 FHOD1 PLEC SNRNP200 | 9.35e-07 | 747 | 166 | 21 | int:SNW1 |
| Interaction | SYCE1 interactions | 1.08e-06 | 127 | 166 | 9 | int:SYCE1 | |
| Interaction | TOP3B interactions | SHROOM3 MYO6 ATP13A1 SPTB LAMB3 AMBRA1 CHD8 LMNB2 ATG2A KANK2 CNTROB DENND1A NCOR1 NCOR2 PWWP2B SYNJ1 RBMX2 UCKL1 BRD4 EIF4G1 SNX8 ANKRD11 MAP3K11 AKAP13 GNA12 KIFC3 PLEC GNAZ SPEN AHNAK2 RAB11FIP3 | 1.09e-06 | 1470 | 166 | 31 | int:TOP3B |
| Interaction | KCTD13 interactions | MAP9 DMXL2 CALD1 MYO6 PPFIA2 PPP1R12B PPFIA1 SPTB SPTBN1 DAPK1 MAP7 KANK2 CCDC177 SPTBN4 ABLIM1 CSE1L LMNA SYNJ1 MYH14 PRRC2C EIF4G1 KNDC1 PLEKHA5 EIF3A PLEC GNAZ CROCC SNRNP200 DYNC1I1 PPP1R12C | 1.10e-06 | 1394 | 166 | 30 | int:KCTD13 |
| Interaction | MAPRE1 interactions | MAP9 DLG5 SPTBN1 UTP14A NUMA1 MARCHF7 LMNB2 MAP7 ABLIM1 PRRC2C BRD4 EIF4G1 PLEKHA5 EIF3A PLEC GOLGA1 RAB11FIP3 | 1.26e-06 | 514 | 166 | 17 | int:MAPRE1 |
| Interaction | YWHAQ interactions | MYH2 DLG5 MYH7 SHROOM3 MYH13 KRT18 ZC3H13 PPFIA1 SPTB NUMA1 DAPK1 MAP7 DENND1A MAP3K12 ABLIM1 CSE1L LMNA LMNB1 BRD4 EIF4G1 PLEKHA5 CCAR2 AKAP13 ANKRD18A PLEC PPP1R12C | 1.56e-06 | 1118 | 166 | 26 | int:YWHAQ |
| Interaction | CCDC88B interactions | 1.78e-06 | 45 | 166 | 6 | int:CCDC88B | |
| Interaction | TNIP1 interactions | CUL4A DLG5 CALD1 RNF31 KRT18 BMP2K MYO6 RRP7BP TNIP2 PPP1R12B SPTBN1 NOL6 UTP14A NUMA1 MAP7 ODF2 STX12 ABLIM1 CSE1L LMNA LMNB1 MYH14 RBMX2 EIF3A KIFC3 PLEC SNRNP200 | 2.34e-06 | 1217 | 166 | 27 | int:TNIP1 |
| Interaction | BTF3 interactions | SMG1 MYH2 MYH7 SHROOM3 CALD1 KRT18 MYO6 SPTB SPTBN1 NUMA1 CNTROB ABLIM1 LMNA LMNB1 MYH14 BRD4 EIF4G1 PLEC SNRNP200 DYNC1I1 PPP1R12C | 2.71e-06 | 799 | 166 | 21 | int:BTF3 |
| Interaction | DISC1 interactions | CCHCR1 MYH7 CALD1 ATP13A1 SPTBN1 LENG1 TSGA10 LAMC1 ZNF318 SPTBN4 LMNA UBR5 SUN2 KIFC3 DYNC1I1 | 2.79e-06 | 429 | 166 | 15 | int:DISC1 |
| Interaction | GUSBP5 interactions | 2.81e-06 | 75 | 166 | 7 | int:GUSBP5 | |
| Interaction | VIM interactions | ANKRD35 TRIM15 CEP85 CALD1 RNF31 KRT18 CNTRL UTP14A TSGA10 CCDC187 PPL ABLIM1 LMNB1 SYNJ1 UBR5 BRD4 EIF4G1 PLEKHA5 KIFC3 PLEC DYNC1I1 | 2.99e-06 | 804 | 166 | 21 | int:VIM |
| Interaction | SIRT7 interactions | CUL4A ZC3H13 SPTBN1 NOL6 UTP14A NUMA1 CHD8 ZNF318 LMNB2 CSE1L LMNA UBR5 MYH14 PRRC2C BRD4 EIF4G1 CCAR2 PLEC SPEN SNRNP200 | 3.41e-06 | 744 | 166 | 20 | int:SIRT7 |
| Interaction | SPTAN1 interactions | MYH7 CALD1 TNIP2 PPFIA1 SPTB SPTBN1 DAPK1 SPTBN4 SPTBN5 FANCF LMNA LMNB1 UBR5 BRD4 PLEKHA5 PLEC | 3.62e-06 | 496 | 166 | 16 | int:SPTAN1 |
| Interaction | TNRC6A interactions | DLG5 CEP85 RNF31 KRT18 TNIP2 CNTRL ODF2 KANK2 CNTROB UBR5 CCAR2 AHNAK2 | 3.73e-06 | 280 | 166 | 12 | int:TNRC6A |
| Interaction | YWHAG interactions | CUL4A DLG5 SHROOM3 RNF31 KRT18 TNIP2 ZC3H13 PPFIA1 DZIP1L SPTBN1 PLEKHG2 MAP7 DENND1A ABLIM1 CSE1L LMNA SYNJ1 PRRC2C EIF4G1 ANKRD11 PLEKHA5 AKAP13 MTCL1 SNRNP200 PPP1R12C CCDC102A AHNAK2 | 3.75e-06 | 1248 | 166 | 27 | int:YWHAG |
| Interaction | SVIL interactions | MYH2 MYH13 CALD1 KRT18 SPTBN1 DAPK1 LMNB2 ODF2 SCAF4 LMNA KIFC3 | 3.81e-06 | 233 | 166 | 11 | int:SVIL |
| Interaction | KRT8 interactions | SMG1 DLG5 CEP85 RNF31 KRT18 TNIP2 MAP7 CNTROB PPL KRT73 SYNJ1 PLEKHA5 MTCL1 KIFC3 PLEC | 3.91e-06 | 441 | 166 | 15 | int:KRT8 |
| Interaction | CDH1 interactions | DLG5 SHROOM3 ABCF3 CALD1 KRT18 MYO6 SPTBN1 KANK2 PPL CCDC43 FANCF ABLIM1 CSE1L LMNA SYNJ1 EIF4G1 PLEKHA5 GNA12 SNAP25 PLEC | 5.48e-06 | 768 | 166 | 20 | int:CDH1 |
| Interaction | NINL interactions | CCHCR1 DLG5 CEP85 BMP2K TNIP2 UTP14A ZFC3H1 ODF2 KANK2 NCOR1 ABLIM1 LMNA UBR5 CCAR2 UQCRH | 6.16e-06 | 458 | 166 | 15 | int:NINL |
| Interaction | PIBF1 interactions | CCHCR1 KRT18 CNTRL TSGA10 LMNB2 ZFC3H1 ODF2 KANK2 KIFC3 GOLGA1 | 6.42e-06 | 200 | 166 | 10 | int:PIBF1 |
| Interaction | LZTS1 interactions | 6.88e-06 | 120 | 166 | 8 | int:LZTS1 | |
| Interaction | SPATA2 interactions | 7.62e-06 | 87 | 166 | 7 | int:SPATA2 | |
| Interaction | CDC5L interactions | SHROOM3 ABCF3 KRT18 DHX40 PPFIA2 PPFIA1 SPTBN1 UTP14A CHD8 MAP7 KANK2 YJU2 CSE1L LMNA UBR5 BRD4 FHOD1 MTCL1 PLEC SPEN SNRNP200 | 7.71e-06 | 855 | 166 | 21 | int:CDC5L |
| Interaction | LRRC31 interactions | MYO6 NUMA1 LAMC1 MYH14 ZC3H4 PRRC2C EIF4G1 AKAP13 PLEC SNRNP200 | 7.98e-06 | 205 | 166 | 10 | int:LRRC31 |
| Interaction | PPP1CB interactions | CALD1 BMP2K MYO6 TNIP2 PPP1R12B SPTBN1 NUMA1 KANK2 NCOR1 ABLIM1 MICALL2 BRD4 EIF4G1 PLEC PPP1R12C | 8.18e-06 | 469 | 166 | 15 | int:PPP1CB |
| Interaction | BMI1 interactions | CUL4A CCHCR1 DLG5 ZC3H13 SPTBN1 NOL6 NUMA1 LMNB2 LMNA UBR5 ZC3H4 PRRC2C BRD4 EIF4G1 PLEC SPEN SNRNP200 CCDC102A | 8.78e-06 | 659 | 166 | 18 | int:BMI1 |
| Interaction | FMR1 interactions | SMG1 TNIP2 SPTBN1 NUMA1 ARHGEF18 MAP7 NCOR1 NCOR2 WTIP PRRC2C BRD4 EIF4G1 CCAR2 MTCL1 DYNC1I1 PPP1R12C | 9.60e-06 | 536 | 166 | 16 | int:FMR1 |
| Interaction | FBXO22 interactions | DCHS2 MYH13 MYO6 KDM5C PPFIA1 SPTBN1 NUMA1 CCDC187 SCAF4 NCOR1 NCOR2 ZC3H4 CROCC2 ANKRD11 PLEKHA5 GOLGA1 | 1.05e-05 | 540 | 166 | 16 | int:FBXO22 |
| Interaction | YAP1 interactions | CALD1 WWC3 MYO6 SPTBN1 NUMA1 CHD8 ZNF318 SCAF4 CCDC43 NCOR1 ABLIM1 LMNA LMNB1 MYH14 PRRC2C SUN2 BRD4 KDM2A GNA12 EIF3A PLEC GNAZ SPEN SNRNP200 | 1.12e-05 | 1095 | 166 | 24 | int:YAP1 |
| Interaction | CCDC14 interactions | 1.17e-05 | 129 | 166 | 8 | int:CCDC14 | |
| Interaction | RCOR1 interactions | CCHCR1 TCF4 PPFIA1 NUMA1 CHD8 ZNF318 NCOR1 NCOR2 LMNB1 SYNJ1 UBR5 BRD4 PLEKHA5 PLEC SPEN | 1.51e-05 | 494 | 166 | 15 | int:RCOR1 |
| Interaction | SYNE3 interactions | CCHCR1 DLG5 SHROOM3 CEP85 LAMC1 ZNF318 KANK2 CNTROB NCOR1 NCOR2 ABLIM1 LMNB1 SUN2 PLEC | 1.94e-05 | 444 | 166 | 14 | int:SYNE3 |
| Interaction | KRT75 interactions | 1.97e-05 | 181 | 166 | 9 | int:KRT75 | |
| Interaction | NCBP2 interactions | 2.24e-05 | 141 | 166 | 8 | int:NCBP2 | |
| Interaction | SMC5 interactions | CUL4A CALD1 KRT18 ZC3H13 NOL6 UTP14A NUMA1 CHD8 ZNF318 SCAF4 NCOR1 NCOR2 LMNA LMNB1 ZC3H4 PRRC2C BRD4 EIF4G1 ANKRD11 UQCRH SPEN SNRNP200 | 2.55e-05 | 1000 | 166 | 22 | int:SMC5 |
| Interaction | NUP50 interactions | UTP14A ZNF318 NCOR1 YJU2 CSE1L LMNA LMNB1 ZC3H4 BRD4 EIF4G1 PLEC SPEN | 2.69e-05 | 341 | 166 | 12 | int:NUP50 |
| Interaction | SRPK2 interactions | ANKRD35 TNIP2 ZC3H13 ZFC3H1 MAP7 KANK2 SCAF4 LMNA LMNB1 PRRC2C RBMX2 EIF4G1 PLEKHA5 AKAP13 EIF3A MTCL1 SPEN SNRNP200 | 2.71e-05 | 717 | 166 | 18 | int:SRPK2 |
| Interaction | SSX2IP interactions | CCHCR1 CEP85 KRT18 CNTRL NUMA1 CCDC187 ODF2 KANK2 ABLIM1 KIFC3 GOLGA1 | 2.79e-05 | 288 | 166 | 11 | int:SSX2IP |
| Interaction | ATG16L1 interactions | CCHCR1 DLG5 SHROOM3 CEP85 WWC3 DHX40 ZC3H13 PPFIA1 CNTRL STX12 CCDC43 PARP10 ABLIM1 LMNB1 MICALL2 PRRC2C RBMX2 AKAP13 KATNIP EIF3A MTCL1 PLEC UQCRH CCDC102A | 2.91e-05 | 1161 | 166 | 24 | int:ATG16L1 |
| Interaction | YWHAZ interactions | DLG5 DMXL2 SHROOM3 KRT18 PPP2R2D PPFIA2 PPFIA1 SPTBN1 ARHGEF18 LAMC1 MAP7 KANK2 DENND1A NCOR1 ABLIM1 LMNA BRD4 FHOD1 MAP3K11 PLEKHA5 CCAR2 AKAP13 KATNIP EIF3A PLEC PPP1R12C | 2.94e-05 | 1319 | 166 | 26 | int:YWHAZ |
| Interaction | CCDC8 interactions | KRT18 NUMA1 LAMC1 ZNF318 LMNB2 ABLIM1 CSE1L LMNA LMNB1 UBR5 MYH14 EIF4G1 UCK2 CCAR2 EIF3A PLEC SNRNP200 | 3.08e-05 | 656 | 166 | 17 | int:CCDC8 |
| Interaction | GSK3B interactions | CUL4A DLG5 PPFIA1 MAP7 KANK2 SPTBN4 CCDC43 PARP10 CSE1L LMNA LMNB1 UBR5 PRRC2C EIF4G1 MAP3K11 PLEKHA5 EIF3A MTCL1 PLEC DYNC1I1 | 3.22e-05 | 868 | 166 | 20 | int:GSK3B |
| Interaction | CBFA2T2 interactions | 3.34e-05 | 45 | 166 | 5 | int:CBFA2T2 | |
| Interaction | SUPT5H interactions | PPP2R2D DHX40 TNIP2 SCAF4 NCOR1 NCOR2 LMNA LMNB1 UBR5 ZC3H4 BRD4 SPEN SNRNP200 | 3.48e-05 | 408 | 166 | 13 | int:SUPT5H |
| Interaction | GOLGA2 interactions | CCHCR1 MYH13 KRT18 LENG1 TSGA10 CCDC187 ZNF318 LMNB2 ZFC3H1 KANK2 STX12 NCOR1 NCOR2 ABLIM1 YJU2 MYH14 ANKRD11 KIFC3 | 3.61e-05 | 733 | 166 | 18 | int:GOLGA2 |
| Interaction | PPP2R1A interactions | CUL4A ABCF3 KRT18 PPP2R2D PPFIA2 PPP1R12B PPFIA1 CNTRL AMBRA1 DAPK1 CCDC43 BRD4 EIF4G1 PLEKHA5 CCAR2 GNA12 MTCL1 | 3.66e-05 | 665 | 166 | 17 | int:PPP2R1A |
| Interaction | YWHAH interactions | DLG5 SHROOM3 KRT18 ZC3H13 PPFIA1 SPTBN1 CNTRL PLEKHG2 MAP7 DENND1A ABLIM1 SYNJ1 PRRC2C BRD4 EIF4G1 ANKRD11 PLEKHA5 CCAR2 AKAP13 MTCL1 PLEC PPP1R12C AHNAK2 | 3.74e-05 | 1102 | 166 | 23 | int:YWHAH |
| Interaction | PHIP interactions | 3.83e-05 | 197 | 166 | 9 | int:PHIP | |
| Interaction | PPP1CC interactions | CALD1 KRT18 BMP2K MYO6 TNIP2 ZC3H13 PPP1R12B SPTBN1 NUMA1 ZNF318 ZFC3H1 NCOR1 LMNA UBR5 ZC3H4 AKAP13 PLEC PPP1R12C | 3.95e-05 | 738 | 166 | 18 | int:PPP1CC |
| Interaction | HDAC1 interactions | CUL4A MYH2 MYH7 KDM5C PPFIA1 GPAM CHD8 ZNF318 DDIT3 NCOR1 NCOR2 PWWP2B LMNB1 SYNJ1 UBR5 MYH14 BRD4 PLEKHA5 CCAR2 RERE PLEC CROCC SPEN | 4.07e-05 | 1108 | 166 | 23 | int:HDAC1 |
| Interaction | UPRT interactions | 4.15e-05 | 24 | 166 | 4 | int:UPRT | |
| Interaction | PINK1 interactions | SHROOM3 RNF31 MYO6 ZC3H13 SPTBN1 NUMA1 AMBRA1 LMNB2 PPL CSE1L LMNA LMNB1 FHOD1 EIF3A PLEC SNRNP200 AHNAK2 | 4.74e-05 | 679 | 166 | 17 | int:PINK1 |
| Interaction | WWTR1 interactions | CEP85 CALD1 NUMA1 DAPK1 CHD8 ZNF318 NCOR1 ABLIM1 LMNB1 SYNJ1 PRRC2C BRD4 PLEKHA5 | 4.92e-05 | 422 | 166 | 13 | int:WWTR1 |
| Interaction | NME7 interactions | 5.53e-05 | 160 | 166 | 8 | int:NME7 | |
| Interaction | BRDT interactions | 5.56e-05 | 81 | 166 | 6 | int:BRDT | |
| Interaction | PSENEN interactions | 5.56e-05 | 81 | 166 | 6 | int:PSENEN | |
| Interaction | PCM1 interactions | CCHCR1 DLG5 CEP85 RNF31 MYO6 CNTRL MAP7 ODF2 CNTROB DENND1A DDIT3 KRT73 GOLGA1 | 6.55e-05 | 434 | 166 | 13 | int:PCM1 |
| Interaction | TLE3 interactions | MYH2 TCF4 MYH7 ZNF318 SCAF4 SPTBN4 NCOR1 NCOR2 UBR5 BRD4 RERE SPEN | 6.91e-05 | 376 | 166 | 12 | int:TLE3 |
| Interaction | ARHGEF5 interactions | 7.29e-05 | 85 | 166 | 6 | int:ARHGEF5 | |
| Interaction | GLDC interactions | CUL4A PPP2R2D SPTBN1 UTP14A MAP7 ABLIM1 LMNA EIF4G1 CCAR2 EIF3A PLEC | 7.43e-05 | 321 | 166 | 11 | int:GLDC |
| Interaction | HERC2 interactions | ARRDC5 TNIP2 PPFIA1 SPTBN1 LMNB2 MAP7 PPL LMNA LMNB1 BRD4 EIF4G1 EIF3A KIFC3 PLEC | 7.51e-05 | 503 | 166 | 14 | int:HERC2 |
| Interaction | GBF1 interactions | CUL4A DLG5 ABCF3 CALD1 CHD8 KANK2 PRRC2C EIF4G1 CCAR2 EIF3A PLEC GOLGA1 AHNAK2 | 7.87e-05 | 442 | 166 | 13 | int:GBF1 |
| Interaction | DTX2 interactions | SHROOM3 CEP85 KANK2 STX12 PARP10 NCOR1 NCOR2 LMNA COQ8A EIF4G1 CROCC | 9.50e-05 | 330 | 166 | 11 | int:DTX2 |
| Interaction | PHLPP1 interactions | DLG5 KRT18 ZNF318 MAP7 KANK2 PRRC2C EIF4G1 PLEKHA5 PLEC SNRNP200 AHNAK2 | 1.03e-04 | 333 | 166 | 11 | int:PHLPP1 |
| Interaction | CHUK interactions | 1.03e-04 | 224 | 166 | 9 | int:CHUK | |
| Interaction | PPP1R13B interactions | 1.08e-04 | 176 | 166 | 8 | int:PPP1R13B | |
| Interaction | NAB2 interactions | 1.18e-04 | 133 | 166 | 7 | int:NAB2 | |
| Interaction | EIF3H interactions | CUL4A CALD1 KRT18 SPTBN1 NUMA1 ADGRB1 KRT73 LMNB1 EIF4G1 EIF3A | 1.20e-04 | 282 | 166 | 10 | int:EIF3H |
| Interaction | PPP2R5A interactions | 1.20e-04 | 93 | 166 | 6 | int:PPP2R5A | |
| Interaction | SCOC interactions | 1.25e-04 | 59 | 166 | 5 | int:SCOC | |
| Interaction | SPTA1 interactions | 1.28e-04 | 94 | 166 | 6 | int:SPTA1 | |
| Interaction | POLA2 interactions | 1.30e-04 | 135 | 166 | 7 | int:POLA2 | |
| Interaction | LINC02910 interactions | 1.35e-04 | 95 | 166 | 6 | int:LINC02910 | |
| Interaction | RBBP5 interactions | 1.38e-04 | 287 | 166 | 10 | int:RBBP5 | |
| Interaction | METTL3 interactions | KRT18 ZC3H13 AMBRA1 LMNB2 LMNA UBR5 UCKL1 BRD4 CCAR2 SNRNP200 | 1.38e-04 | 287 | 166 | 10 | int:METTL3 |
| Interaction | CIT interactions | ANKRD35 MYO6 ZC3H13 SPTB SPTBN1 NOL6 UTP14A ASH1L NUMA1 CHD8 LMNB2 MAP7 SPTBN4 ABLIM1 CSE1L LMNA LMNB1 MYH14 PRRC2C EIF4G1 CCAR2 KDM2A EIF3A PLEC SNRNP200 AHNAK2 | 1.40e-04 | 1450 | 166 | 26 | int:CIT |
| Interaction | SMARCA2 interactions | CUL4A PPFIA2 NUMA1 LAMC1 CNTROB DDIT3 NCOR1 COQ8A BRD4 TEKT1 PPP1R12C | 1.44e-04 | 346 | 166 | 11 | int:SMARCA2 |
| Interaction | EGLN3 interactions | TCF4 DMXL2 CEP85 BMP2K MYO6 PPFIA1 AMBRA1 MARCHF7 CHD8 ZNF318 ANKZF1 NCOR1 NCOR2 CSE1L COQ8A UBR5 WTIP BRD4 ANKRD11 TJAP1 PLEKHA5 AKAP13 MTCL1 UQCRH | 1.61e-04 | 1296 | 166 | 24 | int:EGLN3 |
| Interaction | TSGA10IP interactions | 1.63e-04 | 140 | 166 | 7 | int:TSGA10IP | |
| Interaction | OBSL1 interactions | SHROOM3 CALD1 KRT18 NOL6 UTP14A NUMA1 TSGA10 LMNB2 KANK2 SCAF4 LMNA LMNB1 ZC3H4 CROCC2 CCAR2 EIF3A PLEC SPEN SNRNP200 | 1.66e-04 | 902 | 166 | 19 | int:OBSL1 |
| Interaction | TP53BP2 interactions | 1.79e-04 | 241 | 166 | 9 | int:TP53BP2 | |
| Cytoband | 10q26.3 | 4.05e-05 | 51 | 171 | 4 | 10q26.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19p13 | PLVAP VMAC ATP13A1 ARRDC5 ARHGEF18 LMNB2 KANK2 CCDC194 YJU2 BRD4 ANKRD24 | 2.16e-04 | 797 | 171 | 11 | chr19p13 |
| Cytoband | 19p13.3 | 2.78e-04 | 237 | 171 | 6 | 19p13.3 | |
| GeneFamily | EF-hand domain containing|Spectrins | 3.57e-08 | 7 | 104 | 4 | 1113 | |
| GeneFamily | Lamins | 1.85e-07 | 3 | 104 | 3 | 612 | |
| GeneFamily | Myosin heavy chains | 1.34e-06 | 15 | 104 | 4 | 1098 | |
| GeneFamily | Ankyrin repeat domain containing | ANKRD35 PPP1R12B DAPK1 ANKZF1 KANK2 ANKRD11 ANKRD18A ANKRD24 PPP1R12C | 1.08e-05 | 242 | 104 | 9 | 403 |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 2.50e-05 | 206 | 104 | 8 | 682 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 2.44e-04 | 53 | 104 | 4 | 532 | |
| GeneFamily | PHD finger proteins|Lysine demethylases | 3.43e-04 | 24 | 104 | 3 | 485 | |
| GeneFamily | EF-hand domain containing|Plakins | 8.97e-04 | 8 | 104 | 2 | 939 | |
| GeneFamily | PHD finger proteins | 1.81e-03 | 90 | 104 | 4 | 88 | |
| GeneFamily | Laminin subunits | 2.08e-03 | 12 | 104 | 2 | 626 | |
| GeneFamily | AT-rich interaction domain containing | 3.28e-03 | 15 | 104 | 2 | 418 | |
| GeneFamily | LIM domain containing | 4.76e-03 | 59 | 104 | 3 | 1218 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 6.51e-03 | 66 | 104 | 3 | 722 | |
| GeneFamily | Mitogen-activated protein kinase kinase kinases|RAF family | 8.33e-03 | 24 | 104 | 2 | 654 | |
| Coexpression | LAKE_ADULT_KIDNEY_C3_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S1_S2 | CALD1 MYO6 ZC3H13 ASH1L DENND1A ABLIM1 PRRC2C ANKRD11 PLEKHA5 AKAP13 RERE RAB11FIP3 | 2.28e-08 | 221 | 169 | 12 | M39222 |
| Coexpression | GSE19941_IL10_KO_VS_IL10_KO_AND_NFKBP50_KO_LPS_AND_IL10_STIM_MACROPHAGE_UP | 7.12e-07 | 199 | 169 | 10 | M8115 | |
| Coexpression | GSE14308_TH1_VS_TH17_DN | SMG1 CNTRL LENG1 UTP14A NUMA1 ZFC3H1 CCDC43 UBR5 SUN2 AKAP13 | 7.45e-07 | 200 | 169 | 10 | M3374 |
| Coexpression | LAKE_ADULT_KIDNEY_C5_PROXIMAL_TUBULE_EPITHELIAL_CELLS_STRESS_INFLAM | MYO6 ZC3H13 ZFC3H1 PARP10 NCOR1 PRRC2C BRD4 ANKRD11 PLEKHA5 AKAP13 KDM2A KIFC3 RAB11FIP3 | 3.39e-06 | 417 | 169 | 13 | M39224 |
| Coexpression | HALLMARK_MITOTIC_SPINDLE | 6.13e-06 | 199 | 169 | 9 | M5893 | |
| Coexpression | GSE7509_FCGRIIB_VS_TNFA_IL1B_IL6_PGE_STIM_DC_DN | 7.43e-06 | 154 | 169 | 8 | M6824 | |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_28DY_DN | ATP13A1 ARRDC5 NOL6 ATG2A KDM5D KRT73 PARP10 YJU2 UCKL1 ANKRD11 TJAP1 AKAP13 KATNIP KDM2A EPN1 NAGPA SPEN PPP1R12C | 2.38e-05 | 905 | 169 | 18 | M40865 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | DMXL2 BMP2K PPFIA1 LAMC1 DAPK1 MARCHF7 NCOR2 CSE1L LMNB1 UBR5 ZC3H4 PRRC2C UCK2 AKAP13 EIF3A MTCL1 SPEN | 4.14e-05 | 856 | 169 | 17 | M4500 |
| Coexpression | WANG_TUMOR_INVASIVENESS_UP | SMG1 SHROOM3 ABCF3 CALD1 ZC3H13 SPTBN1 LAMC1 MAP3K12 NCOR1 BRD4 EIF4G1 | 4.24e-05 | 384 | 169 | 11 | M1865 |
| Coexpression | GSE12845_NAIVE_VS_DARKZONE_GC_TONSIL_BCELL_UP | 4.55e-05 | 198 | 169 | 8 | M3200 | |
| Coexpression | GSE40273_GATA1_KO_VS_WT_TREG_DN | 4.88e-05 | 200 | 169 | 8 | M9133 | |
| Coexpression | STEIN_ESRRA_TARGETS_DN | 6.24e-05 | 105 | 169 | 6 | M18160 | |
| Coexpression | WANG_TUMOR_INVASIVENESS_UP | SMG1 SHROOM3 ABCF3 CALD1 ZC3H13 SPTBN1 LAMC1 MAP3K12 NCOR1 BRD4 EIF4G1 | 6.39e-05 | 402 | 169 | 11 | MM1248 |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#2_top-relative-expression-ranked_1000 | SMG1 ZC3H13 SPTBN1 ASH1L CHD8 LYSMD3 PRRC2C EIF4G1 ANKRD11 PLEC | 1.47e-05 | 230 | 167 | 10 | gudmap_developingGonad_e16.5_ovary_1000_k2 |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_k-means-cluster#5_top-relative-expression-ranked_1000 | 2.65e-05 | 151 | 167 | 8 | gudmap_developingGonad_P2_ovary_1000_k5 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#2_top-relative-expression-ranked_1000 | 4.43e-05 | 210 | 167 | 9 | gudmap_developingGonad_e18.5_ovary_1000_k2 | |
| ToppCell | H1299-infected|H1299 / Cell line, Condition and Strain | TCF4 ASH1L CNTROB NCOR1 PRRC2C BRD4 ANKRD11 ANKRD18A EIF3A AHNAK2 | 3.51e-09 | 192 | 169 | 10 | 9cf8049bdc3e0f81ce69042beac72b08d8f38b4e |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Peri/Epineurial_-NAF_epineurial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | NUMA1 OXCT2 ITGA7 CNTROB MAP3K12 NCOR2 ZC3H4 SUN2 FHOD1 PPP1R12C | 5.20e-09 | 200 | 169 | 10 | 24e13b6d9d2d8b29df1f02544ea9c50084d9e75c |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.16e-08 | 195 | 169 | 9 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | control|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 7.65e-08 | 200 | 169 | 9 | 97f36d2c197e03d93a1fc59949d77ae90f6e6a9a | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Peri/Epineurial_|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 7.65e-08 | 200 | 169 | 9 | f7c3a8f5ac156c05ad7335d6d142c154c7d86449 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.35e-07 | 184 | 169 | 8 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.80e-07 | 186 | 169 | 8 | 4e94158db52df41d71e67b02b9895a358eebee0f | |
| ToppCell | droplet-Tongue-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.29e-07 | 188 | 169 | 8 | d62cc37e86b7b186e53aeb7f421c4e5ee28f23bd | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 7.38e-07 | 192 | 169 | 8 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.67e-07 | 193 | 169 | 8 | 3866667dd221612589ae50f5c52f73a183a49ce6 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.98e-07 | 194 | 169 | 8 | 5eaaa81f4b2535f983c424aaef00077089526a5c | |
| ToppCell | 390C-Epithelial_cells-Epithelial-I_(AT1)|390C / Donor, Lineage, Cell class and subclass (all cells) | 7.98e-07 | 194 | 169 | 8 | 88db9f9e80c20ff3474f1f6459dcbdc25aec0b6d | |
| ToppCell | 390C-Epithelial_cells-Epithelial-I_(AT1)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 7.98e-07 | 194 | 169 | 8 | a71728202493d4858342ea2756ea281cd0d99a3a | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.29e-07 | 195 | 169 | 8 | 6477e6e7be5bd8eb99119a12ae16334ccddecd43 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.29e-07 | 195 | 169 | 8 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.95e-07 | 197 | 169 | 8 | adb4e27d73ae2e6a39d212c0ead3ac0ad62d9131 | |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | 9.66e-07 | 199 | 169 | 8 | 61b1ed2db71b96157b92b7535d1955a4033098da | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.66e-07 | 199 | 169 | 8 | 8bf8d7cd774479f065bbbbcb5a4bd1aa91aa0d85 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 9.66e-07 | 199 | 169 | 8 | d43c605a4ff221cf78d91678c15d2ad20f831c7f | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.66e-07 | 199 | 169 | 8 | 0c060ef64341659f4b1247d0264ac12e53a7e12e | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.00e-06 | 200 | 169 | 8 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | NS-control|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.00e-06 | 200 | 169 | 8 | ecbe89ff95d046155b984c8c150e0b9e7278f839 | |
| ToppCell | PND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.91e-06 | 162 | 169 | 7 | 06f5d6c0bb26fe9d5180bc2ebf2c54bf52e715f3 | |
| ToppCell | PND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2-AT1/AT2_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.91e-06 | 162 | 169 | 7 | d0d9c18a73bc0bf4f38308ef2eee8ae20f6a7918 | |
| ToppCell | Control-Epithelial_alveolar-AT_1-Differentiating_AT1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.22e-06 | 177 | 169 | 7 | 9af14a056eb6d88c6f11b09f6d4c0d3448d647d5 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.62e-06 | 179 | 169 | 7 | 04ce3673e46606f63d9c87bcba3a64c96817d812 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.04e-06 | 181 | 169 | 7 | b45b11428d13950369347e051d4d517efb2bd4fd | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Mesenchymal-brain_pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.73e-06 | 184 | 169 | 7 | 89ae8bf1a6c2d355d279d23a5e24a08d9ec2334e | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Mesenchymal-Pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.73e-06 | 184 | 169 | 7 | 34c84ac9a32eaf96f45b79485119cad65905817d | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Mesenchymal-Pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.97e-06 | 185 | 169 | 7 | 5f5df92b328be396941b5812d00454b5ff927d30 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Mesenchymal-brain_pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.97e-06 | 185 | 169 | 7 | 98547c1b1828b76da810ed86082182afaaacdb3f | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.22e-06 | 186 | 169 | 7 | 3aebe163799109ffc67e4e10ee47c2dd0886a92c | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.48e-06 | 187 | 169 | 7 | 58d48128547ee3513d0bf7f78e61b76b1c472ca9 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.75e-06 | 188 | 169 | 7 | 43a3a59f92ad93509d4166bd025aed0b1b39a008 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.30e-06 | 190 | 169 | 7 | e102622f05c7f3e1bd8b224ea159d57033793ee0 | |
| ToppCell | COVID-19-Heart|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.30e-06 | 190 | 169 | 7 | 918ad5037881212008f9f69d5df5da91fd01422c | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.59e-06 | 191 | 169 | 7 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e | |
| ToppCell | COPD-Epithelial-Club|COPD / Disease state, Lineage and Cell class | 8.59e-06 | 191 | 169 | 7 | c909cf5fa0e6519aa93a47d2c3fcd2ae2163cd8d | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.59e-06 | 191 | 169 | 7 | 09db184cb90fe282a14474d7217068c58092c6f8 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.59e-06 | 191 | 169 | 7 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 | |
| ToppCell | 5'-Adult-Distal_Rectal-Mesenchymal-Pericytes|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.19e-06 | 193 | 169 | 7 | 7631bf3362b4fa061ffeab4879ab12c4708dc4c0 | |
| ToppCell | CF-Epithelial|CF / Disease state, Lineage and Cell class | 9.19e-06 | 193 | 169 | 7 | 518901c2e36a79c6189cd0d9e6d36dbd4f56a79c | |
| ToppCell | 5'-Adult-Distal_Rectal-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.19e-06 | 193 | 169 | 7 | 8d15c63f2ae48d0a00d7ef5fdafa917ab8ad0571 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.19e-06 | 193 | 169 | 7 | 82e8a4c40299ffcdfd5a0da711bb9de6fb8a2eaa | |
| ToppCell | CF-Epithelial-Epithelial_cell|CF / Disease state, Lineage and Cell class | 9.19e-06 | 193 | 169 | 7 | 4e3dda27c71b7fdac90d081f0d8e9ca3a8ea7820 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.51e-06 | 194 | 169 | 7 | 4579b4a44f7c731553a284843c296866027d7c0e | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.51e-06 | 194 | 169 | 7 | 7002937e8903e037332a215d00fbc7c7843b33f2 | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.83e-06 | 195 | 169 | 7 | dccc32fcf772e2504de7f663ef0a5bd8e23e92fc | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.83e-06 | 195 | 169 | 7 | 3d6d3de8ada6dce3dc789c15b50cc066e7100496 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.02e-05 | 196 | 169 | 7 | 6ce74aa3f0ce3ca284b67e5a4660ffd2cc9611e0 | |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC-Vascular_SMC_1|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.02e-05 | 196 | 169 | 7 | 40cae477b3906623d1f2a4c630279e710499ce80 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.05e-05 | 197 | 169 | 7 | 3d13a4f2e86422900ee2194e8a1fd1cf9750d5d3 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.05e-05 | 197 | 169 | 7 | 5c4cee914baf7cb43e9cb99cc9e3ae823856dc15 | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 1.05e-05 | 197 | 169 | 7 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_1-Differentiating_AT1|Control_saline / Treatment groups by lineage, cell group, cell type | 1.09e-05 | 198 | 169 | 7 | 85f424cd9bb3117c9e322031024aabb87696ce47 | |
| ToppCell | (00)_Basal-(2)_GFP_FOXI1|(00)_Basal / shred by cell type by condition | 1.12e-05 | 199 | 169 | 7 | 19674e1eaeb51e4196d847cb62aa437c852951d3 | |
| ToppCell | Bronchus_Control_(B.)-Stromal-TX-Smooth_muscle-2|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 1.12e-05 | 199 | 169 | 7 | 2c5ad62919c64ea0242e0984bb9932d2d975f4e3 | |
| ToppCell | PSB-critical-LOC-Epithelial|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.12e-05 | 199 | 169 | 7 | 58dcb0eedafa8629585dc99e53147e2287f49689 | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 1.12e-05 | 199 | 169 | 7 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | NS-critical-d_16-33-Epithelial|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.12e-05 | 199 | 169 | 7 | 3b68197ec01c5f2b315d9e9b6eb02d5f6b5b77a3 | |
| ToppCell | distal-2-mesenchymal-Airway_Smooth_Muscle|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.12e-05 | 199 | 169 | 7 | af226a6c50747dad9ca696463e715913b3ac17c0 | |
| ToppCell | (01)_IL1RL1+-(2)_GFP_FOXI1|(01)_IL1RL1+ / shred by cell type by condition | 1.12e-05 | 199 | 169 | 7 | a2f7d0cabf35b80fe239fae34a77bf9344d5d743 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW26|fetalBrain_Zhong_nature / Sample Type, Dataset, Time_group, and Cell type. | 1.16e-05 | 200 | 169 | 7 | 61d7dd0a78942b069c3f5e75044368dc00e6e8e6 | |
| ToppCell | Macroglial-Astrocytes-SLC14A1---|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.16e-05 | 200 | 169 | 7 | d6fcbf4f4bc1b89a9929d7b114c6b907b6979900 | |
| ToppCell | Macroglial-Astrocytes-SLC14A1----L1-6|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.16e-05 | 200 | 169 | 7 | f861509b54185d89931db64da1b9d81986cc7938 | |
| ToppCell | NS-control-d_0-4-Epithelial|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.16e-05 | 200 | 169 | 7 | d014959891893b6d3854a471fba1dc50c6625a0a | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / Treatment groups by lineage, cell group, cell type | 1.16e-05 | 200 | 169 | 7 | 2dadf317a42a7e27cc1fac74f91b806c93a57108 | |
| ToppCell | 5'-Airway_Nasal|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.16e-05 | 200 | 169 | 7 | f6e967738b4f7b173d6e9977e305f77380dd6c8a | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.16e-05 | 200 | 169 | 7 | 8683445ad5b70748c4a1f12eb77d47623085147e | |
| ToppCell | distal-1-mesenchymal-Airway_Smooth_Muscle|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.16e-05 | 200 | 169 | 7 | 4d4d227d4df7cab7293bc8005ca1b0441983f39a | |
| ToppCell | Macroglial-Astrocytes-SLC14A1|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.16e-05 | 200 | 169 | 7 | 16f468217427921fa18c6d078ffa990eb019b257 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.16e-05 | 200 | 169 | 7 | b68d212159b9d04866ba02ff55c35be247805eec | |
| ToppCell | medial-mesenchymal-Airway_Smooth_Muscle|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.16e-05 | 200 | 169 | 7 | c1d9748aaae489d26e24602a5dcbe7f5fa9a5548 | |
| ToppCell | Bronchial-10x5prime-Stromal-Pericyte|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.16e-05 | 200 | 169 | 7 | 362706445edb33b313684efe50b1f44f5f816e67 | |
| ToppCell | Macroglial-Astrocytes-SLC14A1--|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.16e-05 | 200 | 169 | 7 | 0442894c39eec69850c090957a5dc7bcecd21e04 | |
| ToppCell | medial-mesenchymal-Airway_Smooth_Muscle-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.16e-05 | 200 | 169 | 7 | 6a5047018b12be3bc4b55a64d42e52e96c624003 | |
| ToppCell | Macroglial-Astrocytes-SLC14A1-|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.16e-05 | 200 | 169 | 7 | 01819446deeab9054f5cfe889d53bb49d137dbc0 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type. | 1.16e-05 | 200 | 169 | 7 | 5c7263c862093ad9dbc81d06b16b6f74e8a6b634 | |
| ToppCell | medial-2-mesenchymal-Airway_Smooth_Muscle|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.16e-05 | 200 | 169 | 7 | 16b00eacbea4d75cf814803d3fc0b82c2b8c0a9c | |
| ToppCell | 5'-Airway_Nasal-Epithelial|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.16e-05 | 200 | 169 | 7 | 358d71329921451c7f5a56f1db0f9989af2299dc | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_Tubular-6|TCGA-Stomach / Sample_Type by Project: Shred V9 | 3.26e-05 | 159 | 169 | 6 | 655c0749c238bd68cb797adb83e25a23b8a3cc9d | |
| ToppCell | Adult-Mesenchymal-vascular_smooth_muscle_cell-D122|Adult / Lineage, Cell type, age group and donor | 3.38e-05 | 160 | 169 | 6 | fd14dfeb7021a4b7299371854dc8fc1fd66c8dae | |
| ToppCell | droplet-Thymus-nan-24m-Lymphocytic-double_negative_T_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.44e-05 | 168 | 169 | 6 | de1042267407719f19eb3f580a5df0c9cd0e8273 | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Myeloid-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.74e-05 | 170 | 169 | 6 | f3d5678669dcaed1836014cea543758b7ccc6b46 | |
| ToppCell | 15-Trachea-Mesenchymal-Mesenchyme_RSPO2+|Trachea / Age, Tissue, Lineage and Cell class | 5.39e-05 | 174 | 169 | 6 | fa0681e91724b9a51ee28b214ea5aa14e62ba1a3 | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-pDCs|Myeloid_cells / Location, Cell class and cell subclass | 5.39e-05 | 174 | 169 | 6 | 2274648b80dd74f3c948a779bba3391095964c34 | |
| ToppCell | metastatic_Brain-T/NK_cells-Exhausted_Tfh|metastatic_Brain / Location, Cell class and cell subclass | 5.57e-05 | 175 | 169 | 6 | b732c6a423c28856211002107d8c611dcfb6f265 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.75e-05 | 176 | 169 | 6 | 90f36f10c6ed440a0ca549f23219398853f1fbc3 | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-pDCs|normal_Lymph_Node / Location, Cell class and cell subclass | 5.75e-05 | 176 | 169 | 6 | 476794ef75ce5ab732d78cfeb4944e2f841e3e92 | |
| ToppCell | tumor_Lung-Endothelial_cells-EPCs|tumor_Lung / Location, Cell class and cell subclass | 5.93e-05 | 177 | 169 | 6 | f8b152c09d56a97e8c0482fb1a3964c05f9dc8c5 | |
| ToppCell | droplet-Lung-30m-Epithelial-alveolar_epithelial|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.12e-05 | 178 | 169 | 6 | 76e71fff99cf64302e2e3c0d66dd8ba0ff13624e | |
| ToppCell | droplet-Lung-30m-Epithelial-alveolar_epithelial-type_II_pneumocyte-type_2_alveolar_epithelial_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.12e-05 | 178 | 169 | 6 | 82f78ea1ea3ff3e2347cd8bc2f06e2a10e96f220 | |
| ToppCell | droplet-Lung-30m-Epithelial|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.12e-05 | 178 | 169 | 6 | 5442bc52b8e902da1383f44d97a9f95e471a8d4d | |
| ToppCell | droplet-Lung-30m-Epithelial-alveolar_epithelial-type_II_pneumocyte|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.12e-05 | 178 | 169 | 6 | 523b286ebe0359c7f1902f28cbd71f452626fc0d | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.31e-05 | 179 | 169 | 6 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | COVID-19-Epithelial_cells-AT1|COVID-19 / group, cell type (main and fine annotations) | 6.31e-05 | 179 | 169 | 6 | a0b33bd69ffdfd5d38d80207fb40058a490aa19e | |
| ToppCell | droplet-Lung-LUNG-30m-Epithelial-type_II_pneumocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.71e-05 | 181 | 169 | 6 | cadb18fc73031eb9f779599e15cd7861337fee78 | |
| ToppCell | 3'_v3-blood-Myeloid_Dendritic-pDC|blood / Manually curated celltypes from each tissue | 6.71e-05 | 181 | 169 | 6 | 66d890a105f955dca91d6e5e6c730d1a68ee9233 | |
| ToppCell | droplet-Lung-LUNG-30m-Epithelial-Alveolar_Epithelial_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.71e-05 | 181 | 169 | 6 | 85bec4d3f255f4c61c790325eeb50ad38f709ef2 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.92e-05 | 182 | 169 | 6 | e78ba2c5cae480c16a596ce7c3bf2d480becacf4 | |
| Drug | tetrathionate | 2.59e-09 | 49 | 168 | 8 | CID000026259 | |
| Drug | plakin | 1.67e-07 | 82 | 168 | 8 | CID000018752 | |
| Drug | diethylene glycol distearate | 3.50e-07 | 9 | 168 | 4 | CID000061026 | |
| Drug | nocodazole | MYH2 MYH7 MYH13 KRT18 PPP2R2D MYO6 SPTB NUMA1 LMNB2 MAP7 LMNA LMNB1 MYH14 MAP3K11 EIF3A GOLGA1 | 5.34e-07 | 477 | 168 | 16 | CID000004122 |
| Drug | DKMP | 1.57e-06 | 4 | 168 | 3 | CID003066999 | |
| Drug | ADPribulose | 1.94e-06 | 13 | 168 | 4 | CID000197570 | |
| Drug | STOCK1N-35874; Up 200; 14uM; PC3; HT_HG-U133A | MAP9 SPTBN1 CCNP AMBRA1 MAP7 DDIT3 LMNB1 PRRC2C AKAP13 KDM2A | 1.96e-06 | 195 | 168 | 10 | 6561_UP |
| Drug | Nalbuphine hydrochloride [23277-43-2]; Up 200; 10.2uM; PC3; HT_HG-U133A | TCF4 RNF31 PPP1R12B NUMA1 MAP3K12 FANCF AKAP13 KDM2A EIF3A SPEN | 2.06e-06 | 196 | 168 | 10 | 2063_UP |
| Drug | Buspirone hydrochloride [33386-08-2]; Down 200; 9.4uM; HL60; HT_HG-U133A | TCF4 RNF31 BMP2K AMBRA1 CHD8 LMNB1 MICALL2 FHOD1 GNA12 GOLGA1 | 2.46e-06 | 200 | 168 | 10 | 1282_DN |
| Drug | N-ethylmaleimide | MYH2 MYH7 MYH13 MYO6 SPTBN1 GPAM ADCY5 STX12 PAPOLG SPTBN4 SPTBN5 MYH14 SNAP25 KIFC3 SPEN | 6.24e-06 | 511 | 168 | 15 | CID000004362 |
| Drug | Etifenin [63245-28-3]; Down 200; 12.4uM; PC3; HT_HG-U133A | 7.26e-06 | 178 | 168 | 9 | 3998_DN | |
| Drug | C768-0445; Up 200; 10uM; MCF7; HT_HG-U133A_EA | 1.18e-05 | 189 | 168 | 9 | 973_UP | |
| Drug | Flupentixol dihydrochloride cis-(Z) [2413-38-9]; Down 200; 7.8uM; HL60; HT_HG-U133A | 1.18e-05 | 189 | 168 | 9 | 1288_DN | |
| Drug | MgCl2 | MYH2 MYH7 MYH13 CALD1 MYO6 SPTB SPTBN1 OXCT2 ADCY5 SPTBN4 SPTBN5 MYH14 | 1.34e-05 | 354 | 168 | 12 | CID000024584 |
| Drug | dihydroperillic acid | 1.35e-05 | 7 | 168 | 3 | CID000381256 | |
| Drug | alpha-estradiol; Down 200; 0.01uM; MCF7; HT_HG-U133A_EA | ARHGEF18 ABLIM1 LMNA MICALL2 TJAP1 PLEC NAGPA TBCC RAB11FIP3 | 1.39e-05 | 193 | 168 | 9 | 1048_DN |
| Drug | Loracarbef [121961-22-6]; Up 200; 10.8uM; HL60; HT_HG-U133A | 1.51e-05 | 195 | 168 | 9 | 2970_UP | |
| Drug | Domperidone maleate; Down 200; 7.4uM; HL60; HT_HG-U133A | 1.57e-05 | 196 | 168 | 9 | 1301_DN | |
| Drug | GSK-3 Inhibitor IX; Up 200; 0.5uM; PC3; HT_HG-U133A | 1.57e-05 | 196 | 168 | 9 | 6559_UP | |
| Drug | 1-phenylbiguanide hydrochloride; Up 200; 10uM; MCF7; HG-U133A | 1.64e-05 | 197 | 168 | 9 | 22_UP | |
| Drug | Diazoxide [364-98-7]; Down 200; 17.4uM; HL60; HG-U133A | 1.64e-05 | 197 | 168 | 9 | 1368_DN | |
| Drug | Panthenol (D) [81-13-0]; Up 200; 19.4uM; PC3; HT_HG-U133A | 1.64e-05 | 197 | 168 | 9 | 1802_UP | |
| Drug | Fluoxetine hydrochloride [59333-67-4]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 1.64e-05 | 197 | 168 | 9 | 5356_DN | |
| Drug | Sulfadiazine [68-35-9]; Down 200; 16uM; PC3; HT_HG-U133A | 1.64e-05 | 197 | 168 | 9 | 1810_DN | |
| Drug | Idoxuridine [54-42-2]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 1.70e-05 | 198 | 168 | 9 | 4785_DN | |
| Drug | estradiol, USP; Down 200; 0.01uM; HL60; HG-U133A | 1.70e-05 | 198 | 168 | 9 | 782_DN | |
| Drug | haloperidol; Down 200; 10uM; PC3; HT_HG-U133A | 1.70e-05 | 198 | 168 | 9 | 1244_DN | |
| Drug | Risperidone [106266-06-2]; Up 200; 9.8uM; HL60; HT_HG-U133A | 1.70e-05 | 198 | 168 | 9 | 2947_UP | |
| Drug | Triamcinolone [124-94-7]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 1.77e-05 | 199 | 168 | 9 | 7192_DN | |
| Drug | Proadifen hydrochloride [62-68-0]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 1.85e-05 | 200 | 168 | 9 | 7165_DN | |
| Drug | digalactosyldiacylglycerol (DGDG | 2.27e-05 | 23 | 168 | 4 | CID000447899 | |
| Drug | blebbistatin | 2.49e-05 | 116 | 168 | 7 | CID003476986 | |
| Drug | 2-nitro-5-thiocyanobenzoic acid | 2.73e-05 | 48 | 168 | 5 | CID000092266 | |
| Drug | AC1MLTEF | 2.73e-05 | 48 | 168 | 5 | CID003250248 | |
| Drug | 5-fluorocytidine | 3.21e-05 | 25 | 168 | 4 | CID000016861 | |
| Drug | 1-azidopyrene | 3.21e-05 | 9 | 168 | 3 | CID000115167 | |
| Drug | phenylhydrazine | 3.25e-05 | 82 | 168 | 6 | CID000007516 | |
| Drug | mant-GTP | 3.34e-05 | 50 | 168 | 5 | CID000128647 | |
| Drug | formycin triphosphate | 3.68e-05 | 51 | 168 | 5 | CID000122274 | |
| Drug | AC1LA6KT | 3.68e-05 | 51 | 168 | 5 | CID000508110 | |
| Drug | fullerene C60 | CCHCR1 TCF4 SHROOM3 PLVAP ABCF3 VMAC PPFIA2 ASH1L LAMB3 ARHGEF18 CCDC187 PLEKHG2 ITGA7 PPL PAPOLG NCOR1 COQ8A FAM151A FHOD1 LRRC27 SNX8 GNA12 SNAP25 KIFC3 NAGPA PPP1R12C | 4.01e-05 | 1498 | 168 | 26 | ctd:C069837 |
| Drug | AC1L7UE9 | 5.41e-05 | 2 | 168 | 2 | CID000341622 | |
| Drug | 1-[butoxy(phenyl)methyl]piperidine | 5.41e-05 | 2 | 168 | 2 | CID000219169 | |
| Drug | maleimide | 5.44e-05 | 131 | 168 | 7 | CID000010935 | |
| Drug | AC1NE2UB | 5.81e-05 | 56 | 168 | 5 | CID004635684 | |
| Drug | Coomassie blue | 6.59e-05 | 135 | 168 | 7 | CID000019731 | |
| Drug | dimethyl adipimidate | 6.75e-05 | 30 | 168 | 4 | CID000025738 | |
| Drug | purealin | 6.88e-05 | 58 | 168 | 5 | CID006419303 | |
| Drug | Lanatoside C [17575-22-3]; Down 200; 4uM; MCF7; HT_HG-U133A | 6.91e-05 | 184 | 168 | 8 | 3852_DN | |
| Drug | AC1NRBPQ | 7.23e-05 | 137 | 168 | 7 | CID005288569 | |
| Drug | MAPS | 8.97e-05 | 191 | 168 | 8 | CID000066161 | |
| Drug | PNU-0251126 [267429-19-6]; Down 200; 10uM; PC3; HT_HG-U133A | 9.65e-05 | 193 | 168 | 8 | 7388_DN | |
| Drug | 5211181; Up 200; 12uM; MCF7; HT_HG-U133A_EA | 9.65e-05 | 193 | 168 | 8 | 950_UP | |
| Drug | 2-propylpentanoic acid; Down 200; 500uM; HL60; HT_HG-U133A | 1.00e-04 | 194 | 168 | 8 | 6199_DN | |
| Drug | Hesperetin [520-33-2]; Down 200; 13.2uM; PC3; HG-U133A | 1.00e-04 | 194 | 168 | 8 | 1947_DN | |
| Drug | Miconazole [22916-47-8]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 1.00e-04 | 194 | 168 | 8 | 4960_DN | |
| Drug | Etidronic acid, disodium salt [7414-83-7]; Down 200; 16uM; MCF7; HT_HG-U133A | 1.00e-04 | 194 | 168 | 8 | 4387_DN | |
| Drug | Quinethazone [73-49-4]; Down 200; 13.8uM; PC3; HT_HG-U133A | 1.00e-04 | 194 | 168 | 8 | 4529_DN | |
| Drug | Palmatine chloride [3486-67-7]; Down 200; 10.4uM; MCF7; HT_HG-U133A | 1.04e-04 | 195 | 168 | 8 | 4957_DN | |
| Drug | Oxprenolol hydrochloride [6452-73-9]; Down 200; 13.2uM; MCF7; HT_HG-U133A | 1.04e-04 | 195 | 168 | 8 | 7225_DN | |
| Drug | Sulfamethoxypyridazine [80-35-3]; Down 200; 14.2uM; MCF7; HT_HG-U133A | 1.04e-04 | 195 | 168 | 8 | 3409_DN | |
| Drug | NSC339663 | 1.04e-04 | 250 | 168 | 9 | CID000003892 | |
| Drug | Sulfamethazine sodium salt [1981-58-4]; Down 200; 13.4uM; MCF7; HT_HG-U133A | 1.07e-04 | 196 | 168 | 8 | 3422_DN | |
| Drug | Tolazamide [1156-19-0]; Down 200; 12.8uM; HL60; HT_HG-U133A | 1.07e-04 | 196 | 168 | 8 | 2482_DN | |
| Drug | Sulfinpyrazone [57-96-5]; Down 200; 9.8uM; MCF7; HT_HG-U133A | 1.11e-04 | 197 | 168 | 8 | 6230_DN | |
| Drug | Flavoxate hydrochloride [3717-88-2]; Down 200; 9.4uM; PC3; HT_HG-U133A | 1.11e-04 | 197 | 168 | 8 | 6326_DN | |
| Drug | Meprylcaine hydrochloride [956-03-6]; Down 200; 14.8uM; MCF7; HT_HG-U133A | 1.11e-04 | 197 | 168 | 8 | 3544_DN | |
| Drug | aspirin, USP; Down 200; 100uM; MCF7; HT_HG-U133A | 1.11e-04 | 197 | 168 | 8 | 5564_DN | |
| Drug | Chlormezanone [80-77-3]; Down 200; 14.6uM; MCF7; HT_HG-U133A | 1.11e-04 | 197 | 168 | 8 | 5697_DN | |
| Drug | Antipyrine, 4-hydroxy [1672-63-5]; Down 200; 19.6uM; HL60; HG-U133A | 1.15e-04 | 198 | 168 | 8 | 1997_DN | |
| Drug | Mecamylamine hydrochloride [826-39-1]; Down 200; 19.6uM; MCF7; HT_HG-U133A | 1.15e-04 | 198 | 168 | 8 | 7023_DN | |
| Drug | rofecoxib; Down 200; 10uM; MCF7; HG-U133A | 1.15e-04 | 198 | 168 | 8 | 166_DN | |
| Drug | Vigabatrin [60643-86-9]; Down 200; 31uM; PC3; HT_HG-U133A | 1.15e-04 | 198 | 168 | 8 | 6314_DN | |
| Drug | Glipizide [29094-61-9]; Down 200; 9uM; MCF7; HT_HG-U133A | 1.15e-04 | 198 | 168 | 8 | 4991_DN | |
| Drug | genistein; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 1.15e-04 | 198 | 168 | 8 | 1073_DN | |
| Drug | genistein; Up 200; 10uM; MCF7; HG-U133A | 1.15e-04 | 198 | 168 | 8 | 382_UP | |
| Drug | Flunarizine dihydrochloride [30484-77-6]; Down 200; 8.4uM; MCF7; HT_HG-U133A | 1.15e-04 | 198 | 168 | 8 | 7412_DN | |
| Drug | Oleandomycin phosphate [7060-74-4]; Up 200; 5uM; HL60; HG-U133A | 1.15e-04 | 198 | 168 | 8 | 2018_UP | |
| Drug | clozapine; Up 200; 10uM; PC3; HT_HG-U133A | 1.19e-04 | 199 | 168 | 8 | 1229_UP | |
| Drug | Apomorphine hydrochloride hemihydrate [41372-20-7]; Down 200; 6.4uM; MCF7; HT_HG-U133A | 1.19e-04 | 199 | 168 | 8 | 5283_DN | |
| Drug | Folinic acid calcium salt [6035-45-6]; Down 200; 7.8uM; PC3; HT_HG-U133A | 1.19e-04 | 199 | 168 | 8 | 7401_DN | |
| Drug | 2-Chloropyrazine [14508-49-7]; Up 200; 35uM; MCF7; HT_HG-U133A | 1.19e-04 | 199 | 168 | 8 | 3570_UP | |
| Drug | Morantel tartrate [26155-31-7]; Up 200; 10.8uM; PC3; HT_HG-U133A | 1.19e-04 | 199 | 168 | 8 | 7250_UP | |
| Drug | Molindone hydrochloride [15622-65-8]; Down 200; 12.8uM; MCF7; HT_HG-U133A | 1.19e-04 | 199 | 168 | 8 | 7337_DN | |
| Drug | Acetazolamide [59-66-5]; Down 200; 18uM; MCF7; HT_HG-U133A | 1.19e-04 | 199 | 168 | 8 | 7461_DN | |
| Drug | AC1Q6S1Y | 1.23e-04 | 104 | 168 | 6 | CID000122035 | |
| Drug | W-13, hydrochloride; Down 200; 10uM; MCF7; HG-U133A | 1.23e-04 | 200 | 168 | 8 | 643_DN | |
| Drug | Ketotifen fumarate [34580-14-8]; Down 200; 9.4uM; PC3; HT_HG-U133A | 1.23e-04 | 200 | 168 | 8 | 5842_DN | |
| Drug | S-2-pentyl-4-pentynoic hydroxamic acid | BICDL2 DLG5 DMXL2 SHROOM3 PPP2R2D TNIP2 SPTB CYGB DDIT3 PPL CCDC43 YJU2 MYH14 MAP3K11 EIF3A RERE GNAZ | 1.53e-04 | 834 | 168 | 17 | ctd:C513635 |
| Drug | trifluoperazine | MYH2 MYH7 MYH13 MYO6 SPTBN1 ADCY5 SPTBN4 SPTBN5 MYH14 PPP1R12C | 1.53e-04 | 324 | 168 | 10 | CID000005566 |
| Drug | Aapfcmk | 1.68e-04 | 15 | 168 | 3 | CID005487540 | |
| Drug | PRODAN | 1.68e-04 | 15 | 168 | 3 | CID000028127 | |
| Drug | 6-propionyl-2-(dimethylamino)naphthalene | 2.06e-04 | 16 | 168 | 3 | CID000107729 | |
| Drug | methylselenic acid | PPFIA1 LAMB3 LMNB2 RXYLT1 DDIT3 STX12 NCOR1 NCOR2 UCK2 SNAP25 DYNC1I1 | 2.54e-04 | 412 | 168 | 11 | ctd:C008493 |
| Drug | AC1L9MBG | 2.57e-04 | 42 | 168 | 4 | CID000448761 | |
| Drug | MAR70 | 2.82e-04 | 78 | 168 | 5 | CID000004013 | |
| Drug | irinotecan HCl; Down 200; 100uM; PC3; HT_HG-U133A | 2.86e-04 | 171 | 168 | 7 | 7535_DN | |
| Drug | AC1L9HHR | KRT18 SPTBN1 OXCT2 GPAM LMNB2 ADCY5 SPTBN4 SPTBN5 PARP10 LMNB1 | 3.12e-04 | 354 | 168 | 10 | CID000445141 |
| Drug | EUrd | 3.22e-04 | 4 | 168 | 2 | CID000176869 | |
| Drug | streptovitacin A | 3.22e-04 | 4 | 168 | 2 | CID000091467 | |
| Disease | autosomal recessive Emery-Dreifuss muscular dystrophy 3 (implicated_via_orthology) | 1.75e-07 | 3 | 166 | 3 | DOID:0070248 (implicated_via_orthology) | |
| Disease | congenital muscular dystrophy due to LMNA mutation (implicated_via_orthology) | 1.75e-07 | 3 | 166 | 3 | DOID:0110640 (implicated_via_orthology) | |
| Disease | familial partial lipodystrophy type 2 (implicated_via_orthology) | 1.75e-07 | 3 | 166 | 3 | DOID:0070202 (implicated_via_orthology) | |
| Disease | autosomal dominant Emery-Dreifuss muscular dystrophy 2 (implicated_via_orthology) | 1.75e-07 | 3 | 166 | 3 | DOID:0070247 (implicated_via_orthology) | |
| Disease | myopathy (implicated_via_orthology) | 2.92e-07 | 48 | 166 | 6 | DOID:423 (implicated_via_orthology) | |
| Disease | dilated cardiomyopathy 1A (implicated_via_orthology) | 6.97e-07 | 4 | 166 | 3 | DOID:0110425 (implicated_via_orthology) | |
| Disease | spinocerebellar ataxia type 5 (implicated_via_orthology) | 6.97e-07 | 4 | 166 | 3 | DOID:0050882 (implicated_via_orthology) | |
| Disease | congenital muscular dystrophy (implicated_via_orthology) | 3.45e-06 | 6 | 166 | 3 | DOID:0050557 (implicated_via_orthology) | |
| Disease | progeria (implicated_via_orthology) | 9.59e-06 | 8 | 166 | 3 | DOID:3911 (implicated_via_orthology) | |
| Disease | Neurodevelopmental Disorders | 1.47e-05 | 93 | 166 | 6 | C1535926 | |
| Disease | autosomal dominant hyaline body myopathy (implicated_via_orthology) | 2.04e-05 | 10 | 166 | 3 | DOID:0111269 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2B3 (implicated_via_orthology) | 2.04e-05 | 10 | 166 | 3 | DOID:0111602 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 1 (implicated_via_orthology) | 2.04e-05 | 10 | 166 | 3 | DOID:0111596 (implicated_via_orthology) | |
| Disease | dilated cardiomyopathy 1S (implicated_via_orthology) | 2.04e-05 | 10 | 166 | 3 | DOID:0110454 (implicated_via_orthology) | |
| Disease | congenital myopathy 6 (implicated_via_orthology) | 2.04e-05 | 10 | 166 | 3 | DOID:0080719 (implicated_via_orthology) | |
| Disease | inclusion body myositis (implicated_via_orthology) | 2.04e-05 | 10 | 166 | 3 | DOID:3429 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2A (implicated_via_orthology) | 2.04e-05 | 10 | 166 | 3 | DOID:0111605 (implicated_via_orthology) | |
| Disease | familial hypertrophic cardiomyopathy (implicated_via_orthology) | 2.04e-05 | 10 | 166 | 3 | DOID:0080326 (implicated_via_orthology) | |
| Disease | Emery-Dreifuss muscular dystrophy (implicated_via_orthology) | 3.71e-05 | 12 | 166 | 3 | DOID:11726 (implicated_via_orthology) | |
| Disease | distal myopathy (implicated_via_orthology) | 3.71e-05 | 12 | 166 | 3 | DOID:11720 (implicated_via_orthology) | |
| Disease | myotonia congenita (implicated_via_orthology) | 3.71e-05 | 12 | 166 | 3 | DOID:2106 (implicated_via_orthology) | |
| Disease | restrictive cardiomyopathy (implicated_via_orthology) | 4.80e-05 | 13 | 166 | 3 | DOID:397 (implicated_via_orthology) | |
| Disease | distal arthrogryposis (implicated_via_orthology) | 7.57e-05 | 15 | 166 | 3 | DOID:0050646 (implicated_via_orthology) | |
| Disease | Congenital Fiber Type Disproportion | 1.34e-04 | 18 | 166 | 3 | C0546264 | |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 1.68e-04 | 49 | 166 | 4 | DOID:0060037 (implicated_via_orthology) | |
| Disease | syndromic X-linked intellectual disability Claes-Jensen type (implicated_via_orthology) | 1.87e-04 | 4 | 166 | 2 | DOID:0060809 (implicated_via_orthology) | |
| Disease | Hypothyroidism | 1.87e-04 | 4 | 166 | 2 | C0020676 | |
| Disease | Prostatic Neoplasms | CCHCR1 RNF31 ASH1L LAMC1 PPL NCOR1 MYH14 BRD4 UCK2 AKAP13 EIF3A SPEN | 2.03e-04 | 616 | 166 | 12 | C0033578 |
| Disease | Malignant neoplasm of prostate | CCHCR1 RNF31 ASH1L LAMC1 PPL NCOR1 MYH14 BRD4 UCK2 AKAP13 EIF3A SPEN | 2.03e-04 | 616 | 166 | 12 | C0376358 |
| Disease | muscular dystrophy (implicated_via_orthology) | 2.16e-04 | 21 | 166 | 3 | DOID:9884 (implicated_via_orthology) | |
| Disease | Limb-girdle muscular dystrophy | 4.13e-04 | 26 | 166 | 3 | cv:C0686353 | |
| Disease | PR interval | MYH7 ARRDC5 PPFIA1 SPTBN1 LAMC1 LMNB2 ADCY5 COQ8A TJAP1 PLEC | 5.22e-04 | 495 | 166 | 10 | EFO_0004462 |
| Disease | perivascular space measurement | 6.35e-04 | 30 | 166 | 3 | EFO_0803382 | |
| Disease | X-Linked Emery-Dreifuss Muscular Dystrophy | 6.49e-04 | 7 | 166 | 2 | C0751337 | |
| Disease | cardiomyopathy (implicated_via_orthology) | 7.00e-04 | 71 | 166 | 4 | DOID:0050700 (implicated_via_orthology) | |
| Disease | serum urea measurement | 8.53e-04 | 195 | 166 | 6 | EFO_0009795 | |
| Disease | arteriosclerosis (biomarker_via_orthology) | 8.61e-04 | 8 | 166 | 2 | DOID:2349 (biomarker_via_orthology) | |
| Disease | Polyarthritis, Juvenile, Rheumatoid Factor Positive | 8.92e-04 | 131 | 166 | 5 | C4704862 | |
| Disease | Polyarthritis, Juvenile, Rheumatoid Factor Negative | 8.92e-04 | 131 | 166 | 5 | C4552091 | |
| Disease | Juvenile arthritis | 8.92e-04 | 131 | 166 | 5 | C3495559 | |
| Disease | Juvenile psoriatic arthritis | 8.92e-04 | 131 | 166 | 5 | C3714758 | |
| Disease | Juvenile-Onset Still Disease | 1.02e-03 | 135 | 166 | 5 | C0087031 | |
| Disease | neuroimaging measurement | TCF4 DCHS2 SHROOM3 VMAC SPTBN1 LAMC1 DENND1A NCOR1 ABLIM1 SYNJ1 PRRC2C MAP3K11 GNA12 RERE PLEC | 1.08e-03 | 1069 | 166 | 15 | EFO_0004346 |
| Disease | Moderate albuminuria | 1.10e-03 | 80 | 166 | 4 | HP_0012594 | |
| Disease | dilated cardiomyopathy (implicated_via_orthology) | 1.10e-03 | 80 | 166 | 4 | DOID:12930 (implicated_via_orthology) | |
| Disease | Sclerocystic Ovaries | 1.36e-03 | 144 | 166 | 5 | C1136382 | |
| Disease | Polycystic Ovary Syndrome | 1.36e-03 | 144 | 166 | 5 | C0032460 | |
| Disease | Fuchs endothelial corneal dystrophy | 1.37e-03 | 10 | 166 | 2 | Orphanet_98974 | |
| Disease | Muscular dystrophy, limb-girdle, autosomal dominant | 1.37e-03 | 10 | 166 | 2 | cv:C5675009 | |
| Disease | lean body mass | 1.43e-03 | 379 | 166 | 8 | EFO_0004995 | |
| Disease | influenza A (H1N1) | 1.50e-03 | 87 | 166 | 4 | EFO_1001488 | |
| Disease | creatinine measurement | TCF4 SHROOM3 KRT18 DHX40 PPFIA2 CCNP ARHGEF18 SNUPN ADARB2 MICALL2 PRRC2C ANKRD11 MAP3K11 PLEC | 1.55e-03 | 995 | 166 | 14 | EFO_0004518 |
| Disease | Umbilical hernia | 1.67e-03 | 11 | 166 | 2 | HP_0001537 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 1.73e-03 | 152 | 166 | 5 | DOID:0060041 (implicated_via_orthology) | |
| Disease | liver fat measurement | 1.83e-03 | 43 | 166 | 3 | EFO_0010821 | |
| Disease | Colorectal Carcinoma | LAMB3 LAMC1 LMNB2 ADARB2 DDIT3 KRT73 CSE1L EIF4G1 SNX8 KDM2A SNRNP200 | 2.17e-03 | 702 | 166 | 11 | C0009402 |
| Disease | phosphoglycerides measurement | 2.51e-03 | 48 | 166 | 3 | EFO_0022291 | |
| Disease | Left ventricular noncompaction | 2.74e-03 | 14 | 166 | 2 | C1960469 | |
| Disease | caffeine measurement | 3.15e-03 | 15 | 166 | 2 | EFO_0021177 | |
| Disease | C-X-C motif chemokine 10 measurement | 3.40e-03 | 109 | 166 | 4 | EFO_0008056 | |
| Disease | C-reactive protein measurement | CUL4A MYH2 TCF4 DCHS2 DMXL2 PPP2R2D CCNP KANK2 ADCY5 PPL SCAF4 NCOR1 MYPOP RERE ABCG8 | 3.45e-03 | 1206 | 166 | 15 | EFO_0004458 |
| Disease | urinary albumin to creatinine ratio | 3.50e-03 | 179 | 166 | 5 | EFO_0007778 | |
| Disease | Peripheral Nervous System Diseases | 3.51e-03 | 54 | 166 | 3 | C4721453 | |
| Disease | syndromic intellectual disability (implicated_via_orthology) | 3.58e-03 | 16 | 166 | 2 | DOID:0050888 (implicated_via_orthology) | |
| Disease | Intrahepatic cholestasis of pregnancy | 3.58e-03 | 16 | 166 | 2 | EFO_0009048 | |
| Disease | primary autosomal recessive microcephaly (is_implicated_in) | 3.58e-03 | 16 | 166 | 2 | DOID:0070296 (is_implicated_in) | |
| Disease | coffee consumption measurement | 3.76e-03 | 182 | 166 | 5 | EFO_0006781 | |
| Disease | cortical surface area measurement | TCF4 DCHS2 SHROOM3 ZC3H13 PPP1R12B PPFIA1 SPTBN1 LAMC1 DAPK1 MARCHF7 DENND1A NCOR1 PRRC2C GNA12 MTCL1 RERE | 3.92e-03 | 1345 | 166 | 16 | EFO_0010736 |
| Disease | red blood cell density measurement | SHROOM3 BMP2K SPTBN1 LAMC1 MICALL2 UBR5 ZC3H4 BRD4 AKAP13 KDM2A PLEC CROCC | 4.26e-03 | 880 | 166 | 12 | EFO_0007978 |
| Disease | neutrophil count | CUL4A PPP2R2D ATP13A1 KDM5C SPTBN1 ASH1L MARCHF7 GPAM PLEKHG2 LMNA COQ8A ANKRD11 UCK2 AKAP13 GNA12 RERE | 5.07e-03 | 1382 | 166 | 16 | EFO_0004833 |
| Disease | renal system measurement | 5.59e-03 | 20 | 166 | 2 | EFO_0004742 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VRLAEAEETARTAER | 866 | Q8N163 | |
| RLLRQLRAEAASRSE | 51 | A0A494C0N9 | |
| SSRRGVSREDIEREV | 51 | P53355 | |
| EERKVVEARATRLRD | 801 | Q6ZSZ5 | |
| TARSVRTRRLAAAEE | 2421 | Q9NR48 | |
| DLESEDDERPRSRRH | 1421 | Q9HCK8 | |
| RRSELREADRLLAEA | 1431 | Q7Z7A1 | |
| EEKASALRTRELRSR | 656 | A0A096LP49 | |
| ERCLTRRFRDLDARD | 51 | Q8IVF6 | |
| RRESAEAGRDRKDAL | 941 | Q6UB99 | |
| EREQSRALLRDFARA | 41 | A6NCS6 | |
| SSGREEDDEELLRRR | 586 | O14639 | |
| RSREDEDALEQARRA | 1261 | O60885 | |
| SLRSTDARRREELGD | 326 | O14514 | |
| RDRLSQVLRDLEDES | 931 | Q9HD20 | |
| ESDSVREDLLRRERE | 256 | Q9NUQ8 | |
| EARERELREREALLA | 2606 | Q12802 | |
| SIDRRSREQELATRE | 326 | Q9H221 | |
| DRDTRRDVTLEASRE | 376 | Q66LE6 | |
| REAVAEERRRSGDLA | 871 | Q8N283 | |
| SDRRRLRTESIEEHA | 2296 | Q8TDJ6 | |
| GRAIDARSIDRLRSE | 721 | O95622 | |
| EESSEEDSLRRRLLE | 681 | Q9C0C7 | |
| LEQAREDLRDRDSRL | 791 | Q8TF21 | |
| EDLRDRDSRLRELEA | 796 | Q8TF21 | |
| DEARASRLLAEEEAR | 816 | Q8TF21 | |
| DSFSRAELLRAERRI | 181 | Q9H8S5 | |
| DLLRSNRLEERASSD | 646 | Q9NSY1 | |
| RDLADALLDTERSLR | 1281 | Q2TAZ0 | |
| RREAEASLDNRDELL | 856 | O94823 | |
| RSRSRREAAEAEAEV | 31 | Q96I51 | |
| ARERLELCDERVSSR | 46 | P07919 | |
| EEKTRIRDRGRSSDA | 261 | Q9Y388 | |
| RREDSERSIFVRLKE | 456 | Q9NS39 | |
| SRARESELEQEVRRL | 656 | O75154 | |
| ARGDERESLRLRAAR | 951 | Q9Y4B5 | |
| RSDLSRELEEISERL | 1136 | P12883 | |
| RRISTLDVDRVAREL | 36 | Q8IYY4 | |
| ARKLERDSLRDESQR | 176 | Q96MW1 | |
| TSSSERERDRDRERD | 1791 | Q9Y618 | |
| DRVRSLETENRRLES | 96 | P05783 | |
| RDLEDSLARERDTSR | 321 | P02545 | |
| SLARERDTSRRLLAE | 326 | P02545 | |
| EETLQESLARLARRR | 126 | Q9NPI8 | |
| EERTTRREEESRRLE | 521 | Q14244 | |
| DELIRAITARSARQR | 26 | Q49MG5 | |
| RRSTSRDRLDDIIVL | 51 | Q7Z3D4 | |
| ELEARTRELSRTQEE | 201 | Q92805 | |
| RVRLDSELRSVREVV | 201 | Q86Y46 | |
| FREAEEALRRSSRTA | 111 | O60303 | |
| REAAERSRAEALLAR | 206 | Q96BZ8 | |
| ADARRVLDETARERA | 101 | Q03252 | |
| RRSRLDSSELLRQEA | 241 | A6NEK1 | |
| SLQSRIEDRLERLDD | 381 | P15884 | |
| FEELRALESEARERR | 781 | Q9BY66 | |
| LADARRALDDTARER | 86 | P20700 | |
| RTIRVIERALAEDSD | 236 | O14576 | |
| VDDLRRRLAEAAERE | 66 | A0A1B0GVG4 | |
| RRLAEAAEREEALAR | 71 | A0A1B0GVG4 | |
| TESTRRLDEALRRAG | 151 | A0A1B0GVG4 | |
| RSDIVDSLDEDRLRE | 851 | Q8IY33 | |
| REREARALSLTRALE | 1496 | Q7Z406 | |
| GRRRLQRELEDVTES | 1916 | Q7Z406 | |
| ESLRAELRVTERRAE | 136 | Q15116 | |
| ASERERRRRLLDSLD | 286 | A0A0J9YX94 | |
| LARSLRADIERVARE | 286 | Q9BX97 | |
| QRSDLSRELEEISER | 1141 | Q9UKX2 | |
| RELDVEVSRLEARLS | 1531 | O60437 | |
| VREALRRAFLSADER | 136 | Q8N819 | |
| ISLRDTAASLRLERD | 816 | Q9H6R4 | |
| NLRRERDRAVSELAE | 546 | Q8TDM6 | |
| RDRAVSELAEALRSL | 551 | Q8TDM6 | |
| ERDRLLDTLRETQET | 46 | Q13136 | |
| DTGIIRTARRLDRER | 121 | Q6V1P9 | |
| ERRLSEARLSQRDLS | 421 | Q86WN1 | |
| TISDNLDLRDDSRLR | 176 | Q9BWT3 | |
| LDLRDDSRLRSLDIR | 181 | Q9BWT3 | |
| EREALRRSNEELRSA | 1211 | Q5TZA2 | |
| LALQEESVRRSERER | 1581 | Q5TZA2 | |
| ESVRRSERERRATLD | 1586 | Q5TZA2 | |
| SSEEKEAARRSRRID | 6 | P19086 | |
| EAVDREPRRLSSRRS | 376 | Q9Y2K7 | |
| RREEERRLGDSSLSR | 871 | Q14152 | |
| ALSDREKRALAAERR | 651 | Q9H8Y5 | |
| RLETTEAQLRRSELE | 131 | H7BZ55 | |
| ERSLLSEELSRARRT | 951 | H7BZ55 | |
| SEELSRARRTLERVQ | 956 | H7BZ55 | |
| VRTALLAARAVDRTR | 551 | Q8WW52 | |
| AVLERDTLSIRESRL | 226 | Q9H0C5 | |
| ERERSGEAVDRSLLR | 201 | Q13619 | |
| ERRERSEELSEAERK | 11 | Q8WWM9 | |
| TEAARLFLRQERDAR | 91 | P23610 | |
| SREELRLRELEEARA | 71 | Q96A19 | |
| LRRDIEDLRTTMSDR | 736 | Q6P2H3 | |
| GERRSRLELELQSRE | 236 | Q8N4Y2 | |
| TRLRDDRDACEARRA | 346 | Q8N4Y2 | |
| IRAAADRDRETVRAK | 526 | Q8NI60 | |
| ARRRSRDIDALLARE | 36 | Q03113 | |
| LRRLEEEVRLLRETS | 101 | Q8TD31 | |
| RERREHSLELERARS | 246 | A1A5D9 | |
| LERDSLSRELLRAIR | 426 | A1A5D9 | |
| KEELEEARDIARRRS | 881 | Q04637 | |
| ESRASRVRADEVRLQ | 66 | Q12852 | |
| RERRDLERRTDSSIS | 141 | Q9H992 | |
| LGDVSERLQTDRDRR | 731 | Q8TEH3 | |
| VALLRDEDRLREERA | 131 | Q9Y6I3 | |
| RTLLDARRRLEDQAA | 126 | Q63ZY3 | |
| SRLLDQLRDSRREAE | 736 | Q13751 | |
| FRVDRRDTRLSAEDL | 581 | P11047 | |
| ERTLGELDRDALRRS | 286 | Q76NI1 | |
| ERLTREVEATRRALI | 146 | P35638 | |
| LHLDVDSRDRRRREL | 946 | Q13683 | |
| LERSEQLTRERRSAL | 651 | Q9NQR7 | |
| QLERRSRAAEESLRS | 901 | Q9Y613 | |
| DLSSVARREVREDAR | 706 | Q8IX18 | |
| AATARRSKRERREED | 226 | Q6NUJ5 | |
| RDSRDRESRREKEEA | 1061 | O95104 | |
| RERRGREQSTLESEE | 51 | Q9Y2B1 | |
| ALRRDEARRAKASED | 46 | Q494R4 | |
| ELLSREEELTRAARE | 416 | Q16584 | |
| EVRRLEGELDTARRE | 411 | Q8N137 | |
| ERDRLLDTLRETQES | 41 | O75334 | |
| LERSLEAERASRAER | 1146 | Q14980 | |
| LDAARSSIRVVRVER | 841 | Q53GL7 | |
| TELSQLRRSRDDADR | 756 | Q5BJF6 | |
| RRENERLREALTETT | 691 | Q9BZL4 | |
| RDRAERIASRAIDNA | 236 | Q9Y5X2 | |
| LRIDSSDEDRISEVR | 106 | O43426 | |
| RAKRLEESRAAALRE | 331 | Q9C0I9 | |
| KEVRDRLDRVSREDS | 131 | Q96ER9 | |
| RLARELESREAELRR | 136 | Q9BRQ6 | |
| KAQEEERLSRRLRDS | 226 | Q9BVG8 | |
| ESRNATDESLRRRLI | 451 | Q9HCL2 | |
| LAAAASAERERERER | 1706 | O75376 | |
| ESRLSNLLRRITRED | 146 | Q96Q15 | |
| ITREDDRDRRLATVK | 156 | Q96Q15 | |
| AARRRATVEETARAA | 116 | Q9UK23 | |
| SAAVERARKRREEEE | 456 | Q9Y520 | |
| DESRLSNLLRRITRE | 141 | Q6P435 | |
| ESSVADRRRLFERDG | 1051 | Q8TF72 | |
| RADAQRSRSERLVAE | 26 | Q969V4 | |
| REREREAERAAKASS | 1196 | Q9P2R6 | |
| SSLEQSERRRRLLEL | 36 | O95149 | |
| EELQRRRRLLDAAFD | 131 | A8MXQ7 | |
| EDARTRIIRRAALEF | 296 | Q9BYC2 | |
| ERVLRAFAAELRRLE | 791 | Q9NRC6 | |
| RRADQLADESLESTR | 16 | P60880 | |
| LAAERRARLEESRRL | 626 | Q01082 | |
| EATATADRREQRRTE | 616 | Q8IVF2 | |
| LEELRRRRGETESEE | 536 | Q05682 | |
| LVAREELASALRRDS | 11 | Q96EP0 | |
| RTEAASLRVLERERR | 41 | Q9NSQ0 | |
| ELAASRTARDAALER | 281 | Q8NFZ5 | |
| ELRRRLASATRRTEA | 51 | Q5JTD0 | |
| LASATRRTEALEREL | 56 | Q5JTD0 | |
| SRRDAREVAIEVSLD | 446 | Q6XR72 | |
| RRDLEGSDIDTRRRA | 371 | P55060 | |
| DSDVRLSRRVLRDVR | 161 | Q9HA47 | |
| RVAQLEDRRSTTDLR | 596 | Q86XI8 | |
| REDKLRERDERLSSS | 1411 | Q96T58 | |
| VSRREAALKEDFRRE | 336 | Q9UH99 | |
| LRREELGTEDSRDTL | 416 | Q96PX9 | |
| RAGSRLSAEERQREE | 136 | Q86Y82 | |
| RSRLEALSTERDEIE | 131 | Q9C019 | |
| RTRRLSEQELLDASD | 1701 | Q9UKX3 | |
| EQAARRRAELEASRS | 631 | Q9H254 | |
| RERAAVEELLERAES | 66 | Q15814 | |
| LREFEERRSLRKRSE | 421 | Q9BVJ6 | |
| TLVSERREAVDSALR | 941 | P11277 | |
| SRDREDADRELALLF | 281 | Q86XW9 | |
| DTDADTRLSRRVLRD | 156 | Q9BZX2 | |
| EARKRRLLEDSDSED | 201 | Q9BW85 | |
| ERSVRDVAEVDTVRR | 3141 | Q15149 | |
| RRRLTAEDLFEARII | 3781 | Q15149 | |
| EERARRLAESSKQDR | 781 | Q9UPT8 | |
| DLRRMTTERDSLRER | 111 | Q9BZW7 | |
| LQADRSLIDRTRRDE | 21 | O75643 | |
| VDTDSDIRLVRRLRR | 226 | Q9NWZ5 | |
| SAAERRLEALTRELE | 196 | A6NIX2 | |
| TRELERALEARTARD | 206 | A6NIX2 | |
| SRLERVAREIVETER | 101 | Q9H7P9 | |
| TRRRDDKELDTAIRE | 951 | Q9HAU0 | |
| RRAAELEARLDAAER | 21 | Q2NL98 | |
| VDDEILSGSSRERRR | 1031 | O60293 | |
| ARRKREEEEERSRSL | 321 | Q5VUA4 | |
| RRSAGDVARLEEERE | 291 | Q9ULE0 | |
| RLEEELRRARATSAQ | 306 | Q9ULE0 | |
| DRERERLISDSVERD | 1356 | Q5T200 | |
| RLISDSVERDRDRDR | 1361 | Q5T200 | |
| RDRDRDRTFESSQIE | 1371 | Q5T200 | |
| AREEASLRTLEGRRR | 1886 | O95071 | |
| QSRDLSLEVDRDRDL | 2236 | O95071 | |
| LEELRALESEARERR | 791 | P41229 | |
| ERRDRELALRIAQSE | 1006 | Q9UM54 | |
| LSEDRREDRRADTSA | 156 | Q86VE0 | |
| ARARREAREARLATL | 856 | O60237 | |
| EAREARLATLTSRVE | 861 | O60237 |